An investigation into the role of Lamin A in cell motility and Epithelial to Mesenchymal Transition in Colorectal Cancer by O'MAHONY, KATHERINE,MARGARET
Durham E-Theses
An investigation into the role of Lamin A in cell
motility and Epithelial to Mesenchymal Transition in
Colorectal Cancer
O'MAHONY, KATHERINE,MARGARET
How to cite:
O'MAHONY, KATHERINE,MARGARET (2014) An investigation into the role of Lamin A in cell
motility and Epithelial to Mesenchymal Transition in Colorectal Cancer, Durham theses, Durham
University. Available at Durham E-Theses Online: http://etheses.dur.ac.uk/10636/
Use policy
The full-text may be used and/or reproduced, and given to third parties in any format or medium, without prior permission or
charge, for personal research or study, educational, or not-for-proﬁt purposes provided that:
• a full bibliographic reference is made to the original source
• a link is made to the metadata record in Durham E-Theses
• the full-text is not changed in any way
The full-text must not be sold in any format or medium without the formal permission of the copyright holders.
Please consult the full Durham E-Theses policy for further details.
Academic Support Oﬃce, Durham University, University Oﬃce, Old Elvet, Durham DH1 3HP
e-mail: e-theses.admin@dur.ac.uk Tel: +44 0191 334 6107
http://etheses.dur.ac.uk
2
1 
 
 
 
 
 
 
 
 
An investigation into the role of Lamin A 
in cell motility and Epithelial to 
Mesenchymal Transition in Colorectal 
Cancer 
 
Katherine Margaret O’Mahony 
Degree in Master of Science in Cell Biology 
Supervisor: Chris Hutchison 
 
  
2 
 
Abstract 
 
The Lamin A protein has a number of structural and gene-regulatory roles. 
Recently novel functions for Lamin A have been established in colorectal cancer, 
where expression of Lamin A is a biomarker of poor patient prognosis. 
Colorectal cancer is the fourth most frequent cause of cancer-related death 
world-wide, therefore understanding the molecular mechanisms behind the 
disease is of importance in the development of future therapeutic strategies to 
reduce mortality rates. SW480 colorectal cancer cells that artificially express 
Lamin A (SW480/Lamin A cells) demonstrate increased cell motility and a 
mesenchymal-like morphology, suggesting a more aggressive cancer cell 
phenotype in the presence of Lamin A expression. The aims of this project were 
to further explore how Lamin A expression contributes to a more aggressive 
cancer cell phenotype in SW480 cells. Herein cell density experiments show that 
at low cell density, SW480/Lamin A cells express the mesenchymal markers 
Slug and Vimentin. Scratch wounding assays of SW480/Lamin A cells show that 
cell junctions are absent from these cells at high cell density and the 
cytoskeletons of SW480/Lamin A cells are able to form motile structures. 
Finally silencing of Lamin A in SW480/Lamin A cells caused some of these 
changes to reversed. Together this data indicate that transfection of SW480 cells 
with Lamin A permits a signalling environment conducive to EMT and thus 
patients with high levels of Lamin A in the cells in their tumours may have a 
poorer prognosis due to increased cellular metastatic potential as a result of 
EMT. 
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Chapter 1- Introduction 
 
1.1 Background 
 
As human life expectancy continues to increase, the global burden of age 
related disease must be addressed. Colorectal cancer is the third most 
commonly diagnosed cancer in males and the second in females (Jemal et al, 
2011) and is the fourth most frequent cause of cancer-related deaths 
worldwide (Weitz et al, 2005). The primary cause of this mortality is the 
formation of metastatic tumours that allow the malignant cells to spread to 
secondary sites within the body (Yilmaz and Christofori 2009). The molecular 
mechanisms underlying uncontrolled cellular proliferation, along with the gene 
mutations responsible for the formation of a neoplasm have been studied 
intensively, yet the cellular changes that allow metastasis, the ability for 
malignant cells to invade cardiovascular and lymphatic systems and extravasate 
into other sites in the body, are less well known (Kumar and Hall, 2009). The 
process postulated to be responsible for metastasis is known as Epithelial to 
Mesenchymal Transition (EMT) and has been the recent focus of many studies 
involving breast cancer (Iwatsuki et al. 2009). The process of EMT in colorectal 
cancer has been less well studied, but recent findings have suggested a 
relationship between the expression of the Lamin A gene in SW480 colorectal 
cancer cells and EMT (Foster et al, 2011;Willis et al, 2008b). Expression of Lamin 
A in SW480 cells causes them to be significantly more motile and display some 
morphological, genetic and proteomic characteristics of mesenchymal cells. The 
aim of the following studies was to further elucidate the contribution of Lamin 
A to EMTs in SW480 colorectal cancer cells.  
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1.2 Colorectal Cancer and adenocarcinoma formation. 
 
The epithelial lining of the colon is renewed once every 5-7 days. The structure 
of the colon is such that epithelial stem cells, that allow this renewal process to 
occur, reside in the crypts of the colon.  Crypts are bottle shaped invaginations 
that form proliferative compartments (McDonald et al. 2006) and transit 
amplifying cells, that are created when a stem cell divides, migrate upwards and 
form the fully differentiated epithelial cells that reside at the top of the crypt 
and form the lining of the colon (Figure 1). Lamin A expression has been 
observed in the stem cells of these crypts, suggesting a role for the Lamin A 
protein in the maintenance of the stem cell niche and hence indicating the 
importance of Lamin A expression in epithelial tissue in the colon (Willis et al 
2008a).  
 
 
Figure 1: The structure of the colonic crypt with stem cells labeled in red (Taken from 
Humphries and Wright, 2008). 
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A benign tumour, known as an adenoma, is the result of uncontrolled 
proliferation from a cell that would normally migrate out of the crypt 
compartment to become terminally differentiated. This is the first step towards 
the formation of a malignant adenocarcinoma. In the case of sporadic colorectal 
cancer, a genetic mutation or deletion in a tumour suppressor gene or a 
mutation in an oncogene causes the cell to behave aberrantly within the crypt 
(McDonald et al, 2006). One of the most common genetic changes that can 
occur within the cell is an inactivating mutation in the APC tumour suppressor 
gene that controls the cell cycle. This accounts for 90% of cases with the other 
approximate 10% being caused by heterozygous activating mutations in the β-
catenin gene. Mutations in this gene cause nuclear accumulation of the 
transcription factor β-catenin, which activates the Wnt signaling pathway 
resulting in increased cellular proliferation due to aberrant cell cycle control 
(Pinto and Clevers, 2005).  
 
The transition of a benign adenoma into a malignant adenocarcinoma is 
thought to involve further activating genetic mutation in the proto-oncogene K-
Ras, inactivating mutations in the tumour suppressor gene Smad4 and 
inactivating mutations in the tumour suppressor gene p53 (Pinto and Clevers 
2005). In response to further genetic mutation, cells undergo uncontrolled 
proliferation and penetrate through the crypts into the underlying muscularis. 
When the cells subsequently metastasize, they disseminate into cardiovascular 
or lymphatic transport systems (Fearon and Vogelstein, 1990). The transition 
from healthy epithelial cell to malignant adenocarcinoma is demonstrated in 
Figure 2. 
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Figure.2- The series of genetic alterations involved in the adenoma-carcinoma sequence. 
Mutations in the APC, K-ras, and p53 ultimately result in colorectal cancer (taken from 
http://clinicalvignettes.blogspot.co.uk/2010/12/old-man-with-colonoscopic-findings-of.html) 
 
1.3 Colorectal Cancer- Hereditary forms and global incidence rates. 
 
The vast majority of studies into colorectal cancer have been based on the 
hereditary forms of the condition. These are classified into two groups, 
depending on the formation of colonic adenomas. In 80% of cases, Familial 
adenomatous polyposis (FAP) syndrome occurs when there is a germline 
mutation in the APC tumour suppressor gene, which results in the formation of 
thousands of colonic adenomas in the third and fourth decades of life (Weitz et 
al, 2005). The presence of these polyps increases the likelihood of 
adenocarcinoma formation by almost 100%. Hereditary non-polyposis colon 
cancer (HNPCC) (Kinzler and Vogelstein, 1996) arises as a result of a germline 
mutation in one of the DNA Mismatch Repair (MMR) genes. The resulting 
defect in DNA repair mechanisms leaves the patient susceptible to a mutation 
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in a tumour suppressor gene or an oncogene that will eventually lead to the 
uncontrolled cellular proliferation responsible for the formation of an 
adenocarcinoma (Eshleman et al, 1995). These cases account for only around 
10% of the global incidence, with the rest being sporadic forms of the disease 
(Lynch and de la Chapelle, 2003). 
 
Statistics on the global incidence rates of the disease were carried out by Jemal 
et al (2011) using GLOBOCAN, a standard set of worldwide estimates of cancer 
incidence and mortality. High incidence rates were found in the more 
economically developed areas of Australia, New Zealand, Europe and North 
America whereas rates were low in less developed countries, such as Africa and 
south central Asia. The statistics demonstrate how a lifestyle involving alcohol 
and red meat consumption, which is more typical in developed countries 
increased colorectal cancer incidence. The reduced levels of physically active 
individuals in these populations are also thought to increase incidence of 
colorectal cancer. This lifestyle is also responsible for the high incidence rates 
seen in eastern Asia. 
 
Another factor to be considered is the global availability of treatment. Recent 
improvements in awareness of the disease and screening strategies in the USA 
have allowed a significant decrease in incidence rates due to patient removal of 
precancerous lesions before they develop into malignant carcinomas. This is 
also reflected by higher incidence rates in areas where health infrastructures 
are less established and resources are limited, such as central and Southern 
America and Eastern Europe (Jemal et al 2011)  
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Figure 3- Worldwide colorectal cancer incidence rates are dramatically higher in developed 
countries compared to less developed countries (Taken from the INDOX cancer research 
network website- originally published in the 2008 GLOBOCAN study). 
 
1.4 Lamin Proteins  
  
The Lamin proteins are type V intermediate filament proteins with a well-
conserved domain structure. This consists of a NH2 globular head domain, a 
central α-helical rod domain and a globular COOH terminus. The central portion 
of the filament is composed of linker regions interconnecting coiled-coil 
regions. These linker regions are highly conserved across species, which is 
suggestive of their important role in Lamin structure and function (Fisher et al, 
1986). The Lamin proteins form the lattice-shaped nuclear lamina, situated just 
Incidence rates per 100,000 members of the population 
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below the inner nuclear membrane of the nucleus therefore forming a 
structural cage surrounding the cell’s genetic material (Hutchison, 2002). 
 
 
 
Figure 4- Location, structure and functions of the nuclear lamina. (Taken from Clark et al 
,2008). 
 
The location of the lamina, and the spectrum of diseases that result through the 
acquisition of mutations in the Lamin A gene are highly suggestive of a 
multifunctional role for these proteins in both genetic and structural aspects of 
cell physiology, including tumour progression, control of nuclear architecture, 
regulation of gene expression, apoptosis, senescence and chromatin 
organization and segregation (Foster et al, 2010). 
 
Although the Lamin A protein has multiple functions, its expression is limited to 
differentiated cells within post embryonic tissues, unlike the B-type Lamins, 
whose expression is crucial for cellular development and survival. This has led 
to the conclusion that B-type Lamins constitute the fundaments of the nuclear 
lamina whereas the A-type lamins play more specialized roles (Sullivan et al 
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1999). Elucidation of these roles is commonly studied through observation of 
the Laminopathies- the spectrum of diseases that arise through mutations in 
the LMNA gene. The structural role that Lamin proteins play in cellular integrity 
is demonstrated through mutations in the LMNA gene, which can give rise to 
striated muscle disorders known as Muscular Dystrophies. The Lamin proteins 
form part of the LINC complex, which binds the nucleus to the cytoskeleton 
through a series of proteins (Figure 5). Mutations in Lamin A will compromise 
the structural integrity within this complex, resulting in aberrant cytoskeletal 
organization and positioning of the nucleus that causes disease (Meinke et al 
2011). 
 
 
 
Figure 5- The LINC complex links the nuclear lamina to the actin cytoskeleton via a series of 
proteins (taken from Meinke et al 2011). 
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1.5 Lamin Proteins- Structural and gene regulatory roles 
 
Lamins A and C have number of binding partners that allow a bridge from the 
inner nuclear membrane to the cytoskeleton. The Lamina, situated on the inner 
nuclear membrane is bound to SUN proteins that traverse the inner nuclear 
membrane. Sun proteins bind to Nesprin proteins, that traverse the outer 
nuclear membrane. Outside of the nucleus, Nesprins bind to the actin 
cytoskeleton (Figure 5). Nesprin 3 also binds to intermediate filaments via 
plectin and Nesprin 4 binds to microtubules via kinesins (Schneider et al, 
2010)(Not shown in figure). The structural links made by Lamins, SUNS and 
Nesprins tether the nucleus to the actin cytoskeleton thus allowing mechano-
transduction of the nucleus. This allows nuclear re-orientation and cell 
migration (Luxton et al., 2010). As the nucleus is the largest and most rigid 
organelle, harbouring precious genetic material, its physical properties 
contribute critically to the biomechanical behavior of motile, contractile cells. 
This is reflected in the spectrum of disorders that arise as a result of mutation in 
the nuclear envelope proteins, including many forms of muscular dystrophy 
(Meinke et al., 2011). 
 
The gene-regulatory roles of the Lamin A protein have been indicated by its 
interaction with a number of binding partners situated at the nuclear 
membrane. These include the proteins LAP2α, FACE1, MAN1 and emerin 
(Maraldi et al., 2011). Genetic or epigenetic variations in both Lamin A/C and its 
binding partners results in changes in cellular signaling pathways. When 
signalling proteins normally binding to nuclear membrane proteins are unable 
to do so, aberrant mis-localisation of signal transducers can occur, resulting in 
the de-regulation of signalling pathways that control cellular proliferation and 
15 
 
apoptosis. An example of this is the TGFβ signaling pathway, where mutations 
in Lamin A can cause altered interaction with PPA2 phosphatase. This results in 
aberrant phosphorylation of Smad transcription factors thus preventing their 
activation of target genes within the nucleus (Van Berlo et al., 2005). The 
ultimate result of aberrant cellular signaling is disease, and given the diverse 
number of binding partners and signaling pathways regulated by Lamins A/C, 
the resultant Laminopathies  constitute a wide spectrum of disorders affecting 
muscular and fat tissues, insulin regulation and cellular ageing (Broers et al., 
2006). 
 
1.6 Lamin Proteins and Cancer 
  
As highlighted, Lamin proteins have both structural and gene regulatory roles. 
Both of these functions of Lamin proteins have implications in tumour cell 
progression and metastasis. Mutations in the Lamin proteins and their binding 
partners leads to alterations in nuclear plasticity, cell polarity cues and cell 
motility- all of which play a role in invasion and metastasis (Chow et al., 2012). 
There are also a number of signaling pathways that are commonly found to be 
de-regulated in cancer cells that are also known to be modulated directly or in-
directly by Lamin A/C or its binding partners. Examples include TGFβ, Epidermal 
Growth Factor, WNT and NOTCH (Chow et al., 2012). More recently, the LMNA 
gene has become a prognostic biomarker in both colorectal (Willis et al., 2008b) 
and prostate (Kong et al., 2012) cancers, where it is indicative of poor patient 
prognosis. Lamin A expression within colorectal cancer cells causes them to 
adopt a more motile, aggressive phenotype , which is indicative of a 
multifunctional and highly complex role for Lamin A within the gene expression 
and cytoskeletal organisation of neoplastic cells (Foster et al 2009). 
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1.7 Epithelial to Mesenchymal Transition. 
 
Metastasis of cancerous tumours is responsible for the majority of cancer-
related death due to the difficulty in localizing and removing secondary 
tumours that have been seeded at distant sites (Kumar and Hall, 2009). The 
process by which cells are able to become detached from an epithelial sheet, 
invade the basement membrane of an epithelial tissue and intravasate into the 
cardiovascular or lymphatic system is known as Epithelial to mesenchymal 
transition (EMT). This is thought to be the cause of cancer metastasis and 
chemotherapeutic resistance (Iwatsuki et al 2010). EMT’s may also act to allow 
the continued process of uncontrolled cellular proliferation seen in a carcinoma 
by preventing cellular senescence. The overriding of cell cycle arrest is achieved 
by inducing the expression of certain oncogenes. As a result of continued 
proliferation beyond normal limits, subsequent aggressive dissemination of 
cells from the primary tumour is permissible, thus allowing the invasion of 
cancer cells into the blood and lymph (Kalluri and Weinberg, 2009). 
 
 The process of EMT occurs during normal embryonic development, during 
gastrulation and segment formation, which formed the basis of early study into 
this phenomenon (Bates and Mercurio, 2005). More recently important 
differences have been outlined in this process occurring within metastatic cells, 
where oncogenic activation of signaling molecules is responsible for the 
process. This haphazard signaling is un-like the distinct spatial and temporal 
signaling of certain molecules programmed to orchestrate cell migration within 
a developing embryo (Kalluri and Weinberg, 2009).  
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Of the biological molecules identified in cancerous EMT, NF-кB and TGFβ 
signaling partners and their down-stream transcriptional effectors, Twist and 
Snail have been implicated in oncogenic EMT, where they repress the 
expression of the epithelial cell junctions via repression of E-cadherin 
expression and induce the expression of mesenchymal markers such as 
vimentin (Kumar and Hall, 2009)(Figure 6) 
 
Figure 6- A representation of some of the signaling events causing EMT in 
cancer (taken from Zvaifler, N J (2006). 
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1.8 Inducing EMT’s 
 
Signals originating from the stroma have been shown to be the initial inducers 
of EMT. Early experiments identified growth factors as inducers of EMT by the 
observation that conditioned fibroblast medium, containing HGF, could induce 
polarized epithelial cells to scatter into separate single cells (Stoker and 
Perryman, 1985). In this way EMT is induced by extracellular stimuli through 
activation of kinase-dependent signalling cascades. Other EMT-inducing signals 
that have been identified are EGF, PDGF and TGFß (Kalluri and Weinberg, 2009).  
 
TGFß in particular has been extensively studied and has been identified as an 
important mediator of tumour progression. The role of TGFB as both a 
suppressor of epithelial cell proliferation and a positive regulator of tumour 
progression and metastasis is dependent on the cellular and environmental 
context. In pre-malignant cells, it plays an anti-oncogenic role by functioning as 
a tumour suppressor, regulating senescence and autophagy. However, in 
concert with other signalling pathways, TGFβ signaling can promote epithelial 
cancer once initiation of the transformation into a malignant cell has occurred. 
Furthermore, binding of TGFß to its receptors can activate many non-canonical 
signaling pathways, such as phosphoinositol-3-kinase, mitogen-activated 
protein kinase and small guanosine-triphosphate pathways that are implicated 
in EMT (Grady, 2007). The downstream result of activation of one of the protein 
kinase pathways- the serine/threonine kinase signaling pathway, is the 
ubiquitination and subsequent degradation of RhoA which is a small GTPase 
responsible for the maintenance of apico-basal polarity and junctional stability. 
In this way it causes the dissolution of the cell-cell contacts at E-cadherin based 
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cell junctions which allows the production of metastatic cells from an epithelial 
sheet (Ozdamar et al, 2005). 
 
In order for cancerous cells to accomplish EMT, they must undergo a number of 
molecular changes that causes them to firstly dissolve their cell-cell junctions. 
This process initially involves the down regulation of the homophillic cell 
adhesion molecule E-cadherin (Bates and Mercurio, 2005). This protein 
normally functions in the maintenance of the integrity of epithelial cell layers, 
where it forms adherens junctions that join adjacent cells into a polarized 
epithelial sheet. Its replacement with an increase in N-cadherin expression is 
known as the “cadherin switch” and is a prominent characteristic of cells 
undergoing EMT (Yilmaz and Christofori, 2009).  N-cadherin expression occurs 
when cells undertake a fibroblastic phenotype, and has shown to be correlated 
with motile and metastatic cells (Nieman, 1999).  
 
Upregulation of Vimentin, which is an intermediate protein that forms the 
cytoskeleton in mesenchymal cells, has been shown to play an important role in 
cancer cell metastasis and motility (Ivaska et al, 2007). Mice with targeted 
removal of the Vimentin gene have impaired wound healing, which is indicative 
of the effect a lack of Vimentin has on cell migration. This is thought to be due 
to the fact Vimentin intermediate filaments form part of the cytoskeleton in 
mesenchymal cells, and hence play a role in mechanotransduction within the 
cell that has a direct effect on cellular motility. 
 
The Vimentin cytoskeleton has been found to associate with a6b4 integrin 
proteins, that are located at cell-cell junctions. This is indicative of a further 
function for Vimentin in the regulation of the change in the endothelial barrier 
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seen during the EMT process as it suggests Vimentin may communicate with 
cell junction proteins in order to dissolve cell-cell contacts. The protein is 
thought to be a regulator of a number of key genes that govern the cellular 
motility responsible for metastasis, such as the tyrosine kinase protein AXL. 
Knockdown of Vimentin within breast cancer cell lines has demonstrated down 
regulation of this gene, along with other genes linked to cancer cell migration 
and invasiveness (Vuoriluoto et al, 2011). 
 
Other important governors of this phenotypic change are transcription factors 
that induce the expression of key genes related to the acquisition of a more 
motile cellular phenotype. These transcription factors are also commonly found 
to be employed in non-oncogenic embryonic development, hence underlining 
how oncogenic EMT maintains some similarities with developmental EMT 
(Kalluri and Weinberg 2009). The Snail family of transcription factors have been 
shown to be important inducers of EMT through their powerful ability to 
suppress E-cadherin expression. Snail and Slug are thought to promote the 
formation of ß-catenin T-cell transcription complexes that promote the 
expression of TGFß by binding to the promoter of TGFß3 gene to increase its 
transcription (Hoshino et al, 2009). The downstream effects, as previously 
discussed, result in the promotion of EMT. 
 
A study by Camp et al (2011), has demonstrated that expression of the Slug 
transcription factor resulted in phenotypic and molecular changes characteristic 
of EMT within in a non-invasive rectal cancer cell model. The DLD-1 cell lines 
used were transfected with Slug to allow overexpression to occur. The resulting 
genetic changes gave the cells a significantly enhanced ability to migrate 
through a matrigel matrix along with morphogenetic changes to the cells, such 
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as an increased spindle shape and the formation of motile cytoskeletal 
structures such as pseudopodia. Slug expression inversely correlated with e-
cadherin expression and when the genetically transformed cells were 
transplanted into mice a significant tumour formation rate was recorded, where 
90% of the mice transplanted with the Slug-expressing cells formed tumours 
whereas only 11% of the mice transplanted with the non- Slug cells showed 
tumour formation. 
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1.9 Recent work leading up to this project and aims 
 
Mutation and aberrant expression of the LMNA gene, which codes for the A-
type Lamin protein, is known to give rise to a spectrum of diseases where 
abnormal expression, distribution and structural organisation of the protein 
predominantly affects cells of a mesenchymal lineage. Aside from these 
laminopathies (Broers et al 2006), a new role for Lamin A has been postulated 
within epithelial cancer. It has been shown that patients with colorectal 
adenocarcinomas have a poorer prognosis when Lamin A expression was found 
within their tumours (Willis et al, 2008).  In order to explore this, experiments 
were conducted to elucidate how Lamin A expression affects cell motility and 
invasiveness in a well characterised pre-metastatic colorectal cancer cell line 
SW480. The SW480 cells, which were originally established from a primary 
adenocarcinoma of the colon, were stably transfected with DNA constructs 
encoding a fusion protein of EGFP-lamin A full-length (SW480 Lamin A cells) 
(gift from Dr M. Izumi, Institute of Physical and Chemical Research, Saitama, 
Japan) and EGFP (SW480 control cells) The transfected cells were selected 
depending on their successful increase in expression of Lamin A and viability. 
(detail in Willis et al., 2008).  
 
This model revealed that  Lamin A expression causes a change in cell phenotype 
that allowed the cells to become more motile- demonstrated by their ability to 
close the gap created by wounding a layer of confluent cells (Foster et al, 2011). 
In order to explain this phenomenon, RT PCR was carried out to investigate 
genetic changes in the actin-bundling family of proteins, known as the plastins. 
These proteins play key roles in the organization of the actin cytoskeleton, 
which has a direct effect on cellular motility. Furthermore, their expression has 
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been associated with aggressive and radiation- resistant tumour cells. Analysis 
revealed that T-plastin was up regulated in the GFP-Lamin A transfected cells 
compared to the control cells that were transfected with GFP only. This up-
regulation was coupled with a down regulation in the expression of the cell 
adhesion molecule E-cadherin, which is an indicator of invasive cellular 
behaviour in neoplastic tissue and development of a carcinoma (Willis et al 
2008b). This data, along with the wounding assay gave a strong indication of 
the role that Lamin A expression may play in cytoskeletal re-organization that 
allows cells to adopt a more motile and aggressive phenotype (Foster et al. 
2011). 
 
This thesis looks to extend our knowledge of the contribution of Lamin A in the 
ability of SW480 cells to undergo EMT. Cell density experiments, wounding 
assays and Lamin A gene silencing were used to study classical EMT markers in 
relation to Lamin A gene expression in SW480 cells. 
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Chapter 2- Materials and Methods 
 
2.1 General Chemicals and Materials 
All chemicals were supplied by Sigma-Aldrich (Poole, UK). 
 
2.1.1 Mammalian Cell Lines 
 
The initial SW480 cell line obtained for use was derived from a Broders’ grade 4, 
Dukes B primary colon adenocarcinoma (Leibovitz et al., 1976) and was supplied 
by the European Collection of Cell Cultures (ECACC, Salisbury, Wiltshire, UK). 
Stable transfection of the cells with DNA constructs encoding for EGFP-lamin A 
and EGFP was performed by Dr Naomi Willis (Willis et al., 2008) hence creating 
the SW480/Lamin A (Stable GFP Lamin A expressing) and SW480/Control 
(Stable GFP expressing) cell lines respectively. 
 
2.1.2 Mammalian Cell Culture 
 
Cell culture was performed in a CL2 suite (Containment Level 2 laboratory) 
under a sterile flow hood using aseptic technique. Cells were grown in a CO2 
free, humidified incubator at 37°C. 
 
2.1.3 Subculture 
 
Cells were grown in Leibovitz’s L15 media with Glutamine and Amino Acids 
(supplied by Fischer) and supplemented with 100units/ml of both penicillin and 
streptomycin (supplied by Invitrogen). Media was further supplemented with 
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10% foetal bovine serum lot 057K3395. Cells were grown in both 75cm2 and 
25cm2 flasks supplied by Greiner Bio-One Ltd (Gloucestershire UK). 
Cells were washed at 70%-80% confluency with Versene [137mM NaCl, 2.7mM 
KCl, 8mM Na2HPO4, 1.5mM KH2PO4, 1.5mM EDTA pH 7.4]. Cells were then 
detached from flasks by incubating them in 10% Trypsin in Versene for 4-5 
minutes at 37°C. The cell suspension obtained was neutralised with medium 
and centrifuged (Eppendorf 5810R- programme 4) at 200g for 5 minutes. The 
resulting supernatant was removed using an aspirator and cell pellets were re-
suspended in fresh medium and seeded into new flasks. The cells were split 
according to growth rate, SW480/Lamin A cells were split 1:4-1:6 and 
SW480/Control cells were split 1:3-1:4. 
Versene, Versene with 10% Trypsin and L-15 Media were stored at 4°C and 
heated to 37°C in a chemically treated water bath before use on cells. 
 
2.1.4 Cryopreservation  
 
Cells pellets were obtained as above. Pellets were then re-suspended in 1ml of 
a mixture containing 90% medium and 10% DMSO (dimethylsulfoxide- added 
dropwise to the cells after resuspension in 0.9ml media). Cells were then 
transferred to cryovials that were stored at -150°C. 
To re-establish cultures after freezing, cells were thawed at 37°C and re-
suspended in L-15 medium. Cells were then centrifuged (Eppendorf 5810R- 
programme 4) at 200g for 5 minutes. The supernatant was removed by an 
aspirator and the cell pellets were re-suspended in fresh media before seeding 
cells into 25cm2 flasks. Cells were subsequently passaged into 75cm2 flasks and 
some were cryopreserved to maintain frozen stocks of cells. 
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2.2 Immunoblotting 
 
Immunoblotting was performed to investigate the effect that cell confluency 
has on the expression of proteins in relation to cell motility. 
 
2.2.1 Preparation of whole cell extracts 
 
Cell cultures were grown to varying stages of confluency (50%-90%) before 
washing in Versene at 37°C. Cells were detached from culture flasks using cell 
scrapers (supplied by Greiner Bio-One). Cell suspensions obtained were 
centrifuged at 200g for 5 minutes. In order to generate equal sized pellets at 
various levels of cell confluency, multiple flasks of the same cells were scraped 
at the lower levels of confluence (50-60%) and the suspensions from each flask 
were combined before centrifugation. The resulting supernatant was aspirated 
away from the cell pellet before resuspension in PBS stored at 4°C. The 
resuspension was centrifuged at 200g for 5 minutes (Eppendorf 5810R). The 
supernatant was aspirated away and the resulting cell pellet was snap-frozen in 
a flask of liquid nitrogen before storage at -80°C. Cell samples produced are 
shown in Table 1. 
Table1: Cell types and densities used to make samples for immunoblotting 
Cell confluency Cell Type 
50% SW480/Lamin A 
100% SW480/Lamin A 
50% SW480/Control 
100% SW480/Control 
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Cellular lysis was performed by thawing then incubating pellets on ice in 500 μl 
of a detergent-containing hypotonic buffer [10mM Tris-HCl pH7.4, 10mM KCl, 
3mM MgCl2,0.1 (v/v) Triton X-100] plus 2μl DNase (5units/μl), 2 μl protease 
inhibitor cocktail (Sigma- AEBSF,2 mM ,Aprotinin, 0.3 μM, Bestatin, 130 μM 
EDTA, 1 mM E-64, 14 μM Leupeptin, 1 μM)  and 50μl NEM (n-
ethylmaleimide)].2-10 μl of each sample was then removed in order to calculate 
protein concentration. 500 μl of 2x sample buffer [125mM Tris-HCl pH 6.8, 2% 
(v/v) SDS, 2mM DTT, 20% (v/v) glycerol, 5% (v/v) β-mercaptoethanol and 0.25% 
(w/v) bromophenol blue] was then added.  Samples were stored at ---80°C 
when not in use. 
 
2.2.2 Bradford assay 
 
In order to make accurate comparisons of the levels of protein shown on an 
immunoblot, equal levels of protein must be loaded onto the original resolving 
gel. In order to accomplish this, the level of protein within each individual 
sample must be quantified. The Bradford assay uses colorimetry in order to do 
this. Bradford reagent (Sigma-Aldrich®) contains a Brilliant Blue G dye reagent 
that forms a complex with the available protein in solution. The dye undergoes 
an absorbance shift from 465nm to 595nm upon protein binding therefore 
measuring the absorbance of samples at 595nm prepared with reagent will give 
an accurate quantification of the amount of protein available. 
Protein standards were prepared using BSA (bovine serum albumin) according 
to Table 2 in order to produce a standard curve for use in determination of the 
unknown protein concentration of whole cell extracts. The standards were 
made up in triplicate and their absorbance value was measured at 595nm using 
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a spectrophotometer (). A standard curve- Figure 7, was produced from the 
obtained absorbance values using Microsoft Excel ®. 
 
Table 2 Reagents used for preparation of protein standards for Bradford Assay 
1mg/ml BSA (μl) 0 1 2 5 10 15 
0.1M HCl (μl) 10 10 10 10 10 10 
Lysis Buffer (μl) 2 2 2 2 2 2 
H2O  
(μl) 
88 87 86 83 78 73 
¼ Bradford 
Reagent (μl)  
900 900 900 900 900 900 
 
 
Figure 7: Standard curve produced from the obtained absorbance values in Bradford Assay 
 
To measure unknown protein concentration of samples, 2μl aliquots of protein 
sample were added to 10μl of 0.1M HCl, 88μl of H20 and 900μl of ¼ Bradford 
Reagent (diluted in Milli-Q H2O). Samples were produced in triplicate and the 
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obtained absorbance values were used to extrapolate from the pre-produced 
standard curve in order to determine unknown protein concentration. 
 
2.2.3 One-Dimensional SDS-PAGE 
 
The procedure of Laemmli (Laemmli, 1970) was used to separate proteins 
according to their molecular weight (Mr) on an acrylamide-based gel. Gels were 
cast using the Mini-Protean Electrophoresis System (Biorad). The resolving gel 
used depended on the molecular weight of the proteins of interest. 10% gels 
were used to probe for E-Cadherin (135kDa), GFP-Lamin A (135kDa) Lamin A 
(75kDa). 12% gels were used to probe for Slug (30kDa) and Vimentin (55kDa). 
Gel mixture was made up according to Table 3, where the given quantities are 
suitable to make 2 gels. All solutions were prepared with Milli-Q™ H2O.  Gels 
were pipetted between pre-assembled plates and then butan-1-ol was pipetted 
on top of the gel mixture to ensure to top of the gel was flat. The gel was left 
for 40minutes to set before pouring off the butan-1-ol and pipetting on stacking 
gel mix (Table 3). In order to form wells a teflon comb was inserted into the 
stacking gel, between the gel plates and removed once the gels had set  after 
15 minutes. 
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Table 3- Quantities of Reagents for Acrylamide Gel Preparation 
Amount Reagent 
Resolving 
Gel- 10% 
Resolving 
Gel-12% 
Stacking 
Gel 
ProSieve® 50 acrylamide gel solution 
(Cambrex BioScience Wokingham, 
Ltd., UK),  (ml) 
2.00 
 
2.40 0.50 
Milli-Q™ H20 (ml) 5.30 4.90 3.96 
1.5M Tris-HCl pH 8.8 (ml) 2.50 2.50 0.50 
10% SDS solution (μl) 100 100 50 
10% Ammonium persulphate 
solution (μl) (Fisher Biosciences) 
100 
         
     100  
                   
50 
TEMED (μl) ((N,N,N',N'-
Tetramethylethylenediamine). 
4 
 
4 5 
 
Tank buffer [25mM Tris pH 8.3, 192mM Glycine, 0.1% (v/v) SDS] was used to 
submerge gels that were subsequently loaded with samples containing equal 
concentrations of protein using a fine tipped pipette. A molecular weight 
marker (PageRuler™ Prestained Protein Ladder Plus (Fermentas)) allowed 
molecular weights of visualised proteins to be determined and also 
demonstrated successful transfer of proteins onto a nitrocellulose membrane. 
Gel electrophoresis was performed at 100V and 40mAmp until samples 
migrated to the bottom of the resolving gel. This took around 2 hours.  
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2.2.4 Transfer of protein onto a nitrocellulose membrane. 
Proteins that had been separated on gels were subsequently transferred onto 
nitrocellulose membrane (Protran®, grade BA85, Schleicher and Schuell 
Bioscience Inc., Keene, NH) using the Mini Transblot System (Bio-Rad)  in 
transfer buffer [192mM Glycine, 25mM Tris HCl pH9.2, 20% (v/v) methanol, 
0.1% (v/v) SDS] at 100V, 250mAmp for 1.5 hours at room temperature (25°C).  
 
2.2.5 Antibody Incubations 
 
Membranes were subsequently blocked in 4% (w/v) non fat dry milk in 2x Blot 
Rinse Buffer/Tween-20® (BRB/T) [150mM NaCl, 10mM Tris pH 7.4, 1mM EDTA, 
0.1% (v/v) Tween-20®] at 4°C overnight on an orbital shaker. Primary and 
secondary antibodies were diluted in 2X BRB/T and 1% (v/v) NCS. Dilution and 
incubation time with primary antibody was dependent on the antibody and is 
listed in Table 2.5. All secondary antibodies were Polyclonal HRP-conjugated 
(Stratech Scientific Limited, UK) and were diluted to 1:2000 in BRB/T + 1% (v/v) 
NCS. All secondary antibodies were incubated for 1hr at 25°C. 
AC-40 and GAPDH were used as loading controls as the levels of these proteins 
remain constant independently of cell type and cell density. Primary and 
secondary antibody incubations were separated by washing membranes for 3 X 
5 minutes in BRB/T on an orbital shaker, changing the solution after each wash. 
After the secondary incubation membranes were washed again as above. 
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Table 4- Primary Antibodies used for Immunoblotting 
Antibody Working Dilution Incubation Time on 
orbital shaker at 25°C 
(min) 
Jol 2 (produced onsite) 1:200 45 
Jol 4 (produced onsite) 1:200 45 
Vimentin (Sigma) 1:1000 60 
Slug (Cell Signalling 
Technologies) 
1:500 75 
AC-40 (Anti-β actin) 
(Sigma) 
1:1000 60 
GAPDH (abcam) 1:800 60 or overnight at 4°C 
 
2.2.6 ECL Detection 
 
Approximately 400µl per 5cm2 of enhanced chemiluminescence (ECL) reagent 
(Amersham Biosciences) was added to each membrane for 2 minutes before 
detecting bands in a Dark Room using Hyperfilm™ ECL films (Amersham 
Biosciences) and a Compact X4 Automatic X-ray Film Processor (Xograph 
Imaging Systems Ltd., Gloucestershire, UK). 
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2.2.7 Densitometry 
 
As the size of the dark band on an immunoblot is representative of the level of 
the targeted protein in the sample, amounts of protein were quantified using 
Densitometry, which calculates the optical density of band. Developed X-ray 
films were scanned onto a computer before quantification using Image J 
(Rasband, W.S., ImageJ, U.S National Institutes of Health, Bethesda, Maryland, 
USA http://rsb.info.nih.gov.ij/, 1997-2009. 
 
2.3 Scratch wound assays  
 
Scratch wound assays were performed to investigate the levels of expression of 
proteins in relation to cell motility in both the confluent cells at the centre of 
the scratch wounds and at the wound edges. 
 
2.3.1: Cell Seeding 
 
Glass coverslips with a circumference of 1cm were prepared in 6 well plates in a 
sterile flow cabinet. 3 coverslips were placed in each well using tweezers 
sterilised with ethanol. 200µl of 0.01mg/ml of Poly-D-Lysine (Sigma) was 
pipetted onto each coverslip and left to dry in the hood for 24h. Cellular 
suspensions for seeding were prepared when cells were at 60% confluence. 
Growth flasks of cells were washed in Versene before undergoing trypsinisation 
and pelleting as described in section 1.1 above. Cells were then counted by 
sucking a small sample of suspension into a 10ml pipette then dropping the 
liquid on to the chambers of an improved Neubauer haemocytometer by 
capillary action. Counting grids were viewed under a Zeiss Televal 31 
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microscope and cells that fell within the 16 square grid area were counted. Cells 
that fell on bottom and left sides of the grid were included and cells that fell on 
the top and right hand sides of the grid were ignored. 
As the SW480/Control cells displayed a slightly reduced growth rate in 
comparison to SW480/Lamin A cells, SW480/Control cells were seeded at a 
density of 1x 106 cells per well 24h before seeding 1.1 x 106 of the 
SW480/Lamin A cells in L15 media that has been supplemented as described in 
section 1.1. The cells were then left to grow to 100% confluence for 2-5 days. If 
the growth period required lasted more than 2 days the cells were given fresh 
media on the 3rd day. Once confluent, cells were scratched using a p10 RNAase 
free pipette tip (Star Lab, UK). The media was then changed twice to remove 
any floating cell debris. Cells were then left for 4hr in a CO2 free, humidified 
incubator at 37°C before the wounding reaction was stopped by replacing the 
media with 1x PBS. 
 
2.3.2 Processing for immunofluorescence 
 
Cover Slips were incubated in 500µl per well of 4% Paraformaldehyde (PFA) 
(Agar Scientific) at a pH of 7.4 at 25°C on an orbital shaker for 15min. PFA was 
then removed and the coverslips were washed for 3 x 5min in 1x PBS to remove 
any residual PFA. Cells were then incubated in 400µl per well of 
Permeabilisation buffer [1% (w/v) PBS, 10% (v/v) NCS, 0.1% TritonX-100 
(Sigma)] for 15min at 25°C before washing for 2x 5min in 1x PBS. To avoid non-
specific anti-body binding cells were subsequently blocked in 1% PBS containing 
10% NCS for 1hr on an orbital shaker at 25°C. 
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2.3.3 Primary Antibody Incubations. 
 
Primary Antibodies were prepared in a solution of 1% PBS containing 1%NCS 
and primary antibodies at the dilutions shown in Table 3.3. A number of 
dilutions were experimented with. 50µl of antibody solution was used per 
coverslip. Coverslips were removed from 6 well plates using sterile, fine 
tweezers and incubated in moist, dark staining chambers prepared using 
absorbent paper soaked in 1% PBS covered with aluminium foil and left for 1hr 
at 25°C. 
 
Table 5- List of Antibodies used in immunofluorescent experiments 
Antibody Dilution Ranges Tried Optimal Dilution 
Achieved 
Vimentin (Sigma) 1:50, 1:100, 1:150, 
1:200  
1:200 
Slug (Cell Signalling 
Tech) 
1:50, 1:100, 1:150, 
1:200 
1:100 
E-Cadherin (Abcam) 1:100, 1:150 1:150 
TRITC Phalloidin (No 
secondary antibody) 
1:100, 1:200, 1:400, 
1:600 
1:400 
 
2.3.4 Secondary Antibody Incubations 
 
Before application of secondary antibody coverslips were returned to 6 well 
plates and washed for 3x 5min in 1% PBS. All secondary antibodies used were 
TRITC (Tetramethyl Rhodamine Isothiocyanate) conjugated. 50µl of secondary 
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antibody was applied to each coverslip once the washing steps were complete 
and incubated in moist, dark staining chambers as described above for 1hr at 
25°C. 
 
2.3.5 Mounting and Imaging. 
 
Coverslips were inverted and mounted onto glass slides in 30% (v/v) glycerol 
containing 12% (v/v) Mowiol (Sigma), 2mg/ml 4,6-diamindino-2-phenylindole 
(DAPI) and 2.5% (v/v) 1,4-diazobicyclo-[2.2.2]-octane (DABCO; Sigma) and left 
to dry overnight before imaging using a Zeiss Aksioskopp 40 fluorescent 
microscope (Carl Zeiss GmbH, Germany) fitted with a 40X Oil lens and a Leica 
SP5 Confocal Laser Scanning Microscope fitted with a 40X oil lens. Images were 
viewed and saved in the corresponding software (Zeiss Axiovision) and (Leica 
LAS) before collation in Adobe Photoshop. 
 
2.4. siRNA knockdown of Lamin A and GFP-Lamin A. 
 
siRNA knockdown was performed in order to investigate whether the proteins 
studied in the wounding assays were linked to LMNA gene expression. 
 
2.4.1: Oligonucleotide sequences 
 
Silencer® Select Custom Designed siRNA (Ambion) that targeted sequences in 
exons 11 or 12 of the LMNA gene was used. This allowed us to use an 
oligonucleotide that was specific for lamin A but not lamin C. Previous 
optimisation of sequences had been performed by Foster et al., (2011) and 
therefore the following sequence was used:  
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Sequence 
Name 
Sequence ID 
number 
Sequence (5’-3’) 
Si-1 S238117 Sense: UCAUCUAUCUCAAUCCUAAtt 
Antisense: 
UUAGGAUUGAGAUAGAUGAga 
  
Silencer® Select Negative Control #1 siRNA (si-c) was used as a negative control. 
 
2.4.2 Transfection in 6 well plates 
 
24 Hours before transfection cells were washed and trypsinized as described in 
section 2.1 before pelleting and counting using a haemocytometer as described 
in section 3.1. Cells were seeded at a density of 4 x 105 cells per well using 
antibiotic-free L15 media + 10% FBS. Media was changed immediately 
preceding transfection using 1.5ml of antiobiotic free L15 media with 10% FBS. 
In a 2ml RNAse free tube 10µl Oligofectamine™ (Invitrogen) reagent was 
prepared in 160µl serum and antibiotic free L-15 medium for each well and 
incubated for 10min. 10 µl [20µM] Lamin A siRNA or 10µl scrambled siRNA that 
had been prepared in 40µl of serum and antibiotic-free media for each well was 
added to the tube and left for 20min.The total amount of reaction mixture for 
each well (220 µl) was then added to the well before rocking the plates gently 
to ensure even mixing. Plates of cells were then grown in a CO2 free, humidified 
incubator at 37°C. Media was changed using antibiotic-free L15 with 10% FBS 
after 24h and subsequently every 48h as was necessary.  
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After 48h cells were subcultured as described in section 2.1. The cells were 
passaged 1:3 so that a cellular suspension that comprised 1/3 of the original 
pellet was seeded onto pre-prepared coverslips that were treated as described 
in section 3.1. Antiobiotic free L15 media supplemented with 10% FBS was then 
added to each well to create a total volume of 2ml per well. Cells were then left 
for a further 48h, 62h or 96h as shown in Table 6 before the Media was 
replaced with 1% PBS thus stopping the knockdown reaction. The coverslips 
were then immediately processed for immunofluorescence as described in 
section 2.3.2, 2.3.3,2.3.4 and 2.3.5 using the antibodies shown in Table 7. 
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Table 6- Tabulated overview of siRNA experiments performed in 6 well plates. 
 
Experiment 
 
0h 
 
24h 
 
48h 
 
96h 
 
120h 
 
144h 
 
siRNA 1 
 
Transfect 
Cells 
 
Change Media 
 
Subculture 
on to 
coverslips 
 
Add 1% PBS 
process for 
immuno- 
fluorescence 
  
 
siRNA 2 
 
Transfect 
Cells 
 
Change Media 
 
Subculture 
on to 
coverslips 
 
Change Media 
 
Add 1% PBS 
process for 
immuno-
fluorescence 
 
 
siRNA 3 
 
Transfect 
Cells 
 
Change Media 
 
Subculture 
on to 
coverslips 
 
Change Media 
  
Add 1% PBS 
process for 
immuno- 
fluorescence 
40 
 
Table 7-Primary Antibodies used in siRNA knockdown experiments 
Antibody Dilution 
Slug (Cell Signalling Technologies) 1:150 
E-Cadherin (Abcam) 1:150 
Vimentin (Sigma) 1:200 
EGFR (Santa Cruz Biotechnology) 1:150 
Fibronectin (Abcam) 1:150 
T-Plastin (Abcam) 1:150 
Phalloidin 1:400 
 
Coverslips were subsequently viewed and Imaged using a Leica SP5 Confocal 
Laser Scanning Microscope fitted with a 40X oil lens. Images were viewed and 
saved in the corresponding software Leica LAS before collation in Adobe 
Photoshop. 
 
2.4.3 Transfection in T25 culture flasks. 
 
24 Hours before transfection cells were washed and trypsinized as described in 
section 2.1 before pelleting and counting using a haemocytometer as described 
in section 3.1. Cells were seeded at a density of 3.5 x 105 cells per flask using 
5ml of antibiotic-free L15 media + 10% FBS per flask. 
In a 2ml RNAse free tube, 20µl Oligofectamine™ (Invitrogen) reagent was 
prepared with 320µl serum and antibiotic free L-15 medium for each flask. The 
mixture was mixed gently using a pipette and left for 10min. 30 µl [20µM] 
Lamin A siRNA or 30µl scrambled siRNA that had been prepared in 80µl of 
serum and antibiotic-free media was needed per flask and was subsequently 
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added to the Oligofectamine™ mixture. This mixture was then left for 20min. 
The total amount of reaction mixture per flask (400µl) was subsequently added 
to each flask and mixed gently. Flasks were left to grow in a CO2 free, humidified 
incubator at 37°C. The media was changed after 24h using anti-biotic free L15 
media supplemented with 10% FBS. 
After 48h, cells were subcultured into T75 flasks using a versene wash and 
trypsinization as described in section 1.1. The entire pellet obtained by 
centrifugation was re-suspended in 12ml of fresh antibiotic free L15 media 
supplemented with 10% FBS. Cells were then harvested for lysate preparation 
using a plastic cell scraper as described in section 2.1. Samples were taken 
every 24h as demonstrated in Table 8. 
 
The cell pellets obtained were then stored at -80°C before being processed for 
immunoblotting as described in sections 2- 2.7. The only primary antibody used 
in this experiment was Jol2, which was incubated as described in Section 2.2.5. 
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Experiment 0h 24h 48h 62h 96h 120h 144h 
siRNA 1 Transfect 
Cells 
(3x T25 
flask for 
control 
siRNA and 
si-1) 
Change 
Media 
Harvest 1 flask for 
immunoblotting 
Subculture 
remaining flasks 
→ T75cm3  
Harvest 1 flask for 
immunoblotting 
 
Harvest 1 flask for 
immunoblotting 
 
  
siRNA 2 Transfect 
Cells 
(4x T25 
flask for 
control 
siRNA and 
si-1) 
Change 
Media 
Harvest 1 flask for 
immunoblotting 
Subculture 
remaining flasks 
→ T75cm3  
Harvest 1 flask for 
immunoblotting 
 
Harvest 1 flask for 
immunoblotting 
 
Harvest 1 flask for 
immunoblotting 
 
 
siRNA 3 Transfect 
Cells 
(5x T25 
flask for 
control 
siRNA and 
si-1) 
Change 
Media 
Harvest 1 flask for 
immunoblotting 
Subculture 
remaining flasks 
→ T75cm3  
Harvest 1 flask for 
immunoblotting 
Harvest 1 flask for 
immunoblotting 
 
Harvest 1 flask for 
immunoblotting 
 
Harvest 1 flask for 
immunoblotting 
 
 
Table 8: Tabulated overview of siRNA experiments in T25cm3 cell culture flask 
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Chapter 3: Cell density experiment results 
 
3.1 Background and experiment aims 
 
Studies by Foster, 2011 (PhD thesis) have explored the effect that Lamin A over-
expression has on sub-confluent and confluent SW480 cell cultures. The 
endogenous expression of Lamin A was shown to be higher in sub-confluent 
SW480 cultures that have been transfected with GFP- Lamin A in comparison to 
their confluent counterparts. This is thought to be directly related to the motile 
behaviour of the cells, whereby at sub-confluence, when the cells are free to 
move, the Lamin A protein expression is up-regulated. The reasons behind this 
phenomenon are currently not well known but it has been established using 
proteomic techniques that the transfection of SW480 cells with Lamin A also 
leads to changes in the proteins situated within the cytoskeletal fraction of the 
cells in relation to cell motility, including an up-regulation in the intermediate 
filament Vimentin (Foster et al., 2011). Microarray data generated using SW480 
cells transfected with GFP Lamin A also revealed an up-regulation in the 
transcription factor Slug compared to the same cell line that was transfected 
with GFP only (Foster, 2011). Ingenuity Pathways Analysis (IPA) carried out on 
this microarray data indicated the up-regulation of Slug with Vimentin may 
form part of a genetic regulatory network that may contribute to Epithelial to 
Mesenchymal Transition (EMT) (Foster 2011, PhD thesis). It has also been 
documented in the literature that cells undergoing EMT may demonstrate high 
expression levels of the Transcription factor Slug along with an up-regulation in 
Vimentin (Yilmaz and Christofori, 2009).  This shows that Vimentin and Slug are 
important mediators of an increase in cell motility as part of EMT. The aim of 
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these immunoblotting experiments was therefore to assess the levels of 
Vimentin and Slug in SW480/Lamin A cells in sparse and confluent culture 
conditions to determine if there are differences at low cell density. The extent 
to which Lamin A contributes to differences in protein expression was 
determined by comparing SW480 cells that have been transfected with GFP 
Lamin A (in this thesis referenced as “SW480/Lamin A”) and Control cells that 
have been transfected with GFP only (in this thesis referenced as 
“SW480/Control”). Both kinds of cell cultures were collected at 50% confluency 
where none of the cells formed contacts with one another (sparse culture- low 
cell density) and 100% confluency  where all of the cells formed contacts with 
one another (high cell density). These two conditions were chosen as the ability 
for cells to form contacts in culture has been shown to affect their expression of 
mesenchymal markers (Conacci- Sorrell et al, 2003). 
 
3.2  Controls 
 
Experimental normalization was performed through the use of protein loading 
controls, whereby the expression of the house-keeping proteins GAPDH and β-
actin were determined using the relevant antibodies. The level of expression of 
protein of interest was then expressed as a ratio to the level of loading control 
protein. This standardized the protein levels between the different cellular 
samples and thus any up-regulation of proteins of interest could be determined 
as a result of cell confluency and the presence of Lamin A overexpression, 
instead of being an artifact of the experimental design. 
 
 
 
45 
 
3.3 Statistical analysis  
 
Experiments were carried out in triplicate. Results were analysed using 
Densitometric analysis, on Image J software, where the total internal density of 
the protein bands was calculated for each replicate and its corresponding 
loading control. Statistical analysis used the average relative value of amount of 
protein for each sample type. Sub-confluent versus confluent SW480/Lamin A 
cell cultures were compared using a one-tailed, paired T-test. Sub-confluent 
versus confluent SW480/Control cells were also compared using a one-tailed, 
paired T-test. Sub-confluent SW480/Lamin A cells were then compared to sub-
confluent SW480/Control cells using an one-tailed, un-paired T-test. Confluent 
SW480/Lamin A cells versus confluent SW480/Control cells were also compared 
using an un-paired T-test.  
 
3.4 Lamin A expression. 
 
The level of GFP-Lamin A(95kDa) has not been included in this data analysis as 
the cell-density dependent changes observed in the expression of endogenous 
Lamin A  (75kDa) were more significant than those observed for GFP-Lamin A 
(95kDa). This may be due to the fact that the initial transfection and 
characterization of SW480 cells with GFP-Lamin A also lead to an increase in the 
levels of endogenous lamin A, possibly due to increased protein stabilization 
due to the presence of GFP-Lamin A in the transfected SW480 cells (Willis- 
2005- e thesis gives more details and Foster, 2011 e-thesis confirms 
endogenous expression of Lamin A (75kDa) is increased in the SW480 cells 
transfected with GFP-Lamin A). 
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Figure 8:  Immunoblotting of Lamin A using a Jol2 (anti Lamin A/C)  antibody with β-Actin as a 
loading control.  
  
In the sub-confluent samples of SW480/Lamin A cells (LS- column 1) a strong 
band was observed at the 75kDa marker, indicating the expression of 
endogenous  Lamin A whereas is the confluent samples of SW480/Lamin A cells 
(LC- column 2) only a faint protein band was observed at 75kDa, indicating the 
relative levels of endogenous Lamin A protein expression decreased at 
confluence in the SW480/Lamin A cells. In the SW480/Control cultures a protein 
band was observed in both the sub-confluent (GS-column 3) and the confluent 
(GC-column 4) samples at 75kDa. Both of these samples had a greater level of 
protein overall, shown by the more dense protein bands obtained when the 
samples GS and GC samples were probed for β-Actin expression as a loading 
control in comparison to the LS and LC samples. 
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Figure 9: A graph showing the average relative levels of Lamin A protein (to a β-actin loading 
control) across 3 experimental immunoblotting replicates. Lines indicate where a T-test has 
demonstrated a statistically significant difference in protein level. *= P <0.05  **= P < 0.005. 
Samples are in the same order left to right as in figure 8 
 
As Figure 9 shows, once protein levels were standardized against the β-Actin 
loading control, Lamin A expression was highest in the sub-confluent SW480 
cell sample (LS). This level of expression was statistically significantly higher 
than both the confluent SW480/Lamin A cells (LC) (P=0.011) and the sub-
confluent SW480/Control cells (GS)(P=0.001) and thus the highest levels of 
Lamin A expression occurred in the sub-confluent SW480/Lamin A sample. The 
change in Lamin A expression in sub-confluent (GS) versus confluent (GC) 
SW480/Control cells was not significant. 
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3.5: Vimentin expression  
 
There was also a statistically significant difference in the level of Vimentin 
expression between SW480/Lamin A sub-confluent cultures and SW480/Control 
sub-confluent cultures (P value: 0.001). Vimentin expression in the sub-
confluent cultures of SW480/Lamin A cells was also significantly higher 
compared to the SW480/Lamin A confluent cell cultures (P value: 0.002). 
 
 
Figure 10: Immunoblotting of the intermediate filament protein Vimentin(molecular weight 
55kDa) using a Vimentin antibody with β-Actin as a loading control 
 
In the sub-confluent SW480/Lamin A cells (LS-column 1) a strong protein band 
was observed for Vimentin at 55kDa. In the confluent SW480/Lamin A samples 
(LC- column 2) a band at 55kDa was of similar density to the LS band, but there 
was more protein present overall in the confluent SW480/Lamin A cells as 
shown by a denser band for the loading control (LC- column 2- β-actin). This 
indicates that the relative Vimentin expression was reduced in the confluent 
SW480/Lamin A samples (LC) compared to the sub-confluent SW480/Lamin A 
samples (LS). In the SW480/Control samples a faint band at 55kDa was seen in 
the sub-confluent cells (GS- column 3) and a more dense band at 55kDa was 
seen in the confluent cells (GC- column 4). As more protein was present in the 
confluent SW480/Control sample(column 4) compared to the sub-confluent 
sample (column 3), which was shown by the denser loading control band in 
column 4, this suggests little or no change in the relative expression of Vimentin 
in sub-confluent versus confluent SW480/Control cells. 
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Figure 11: A Graph showing the average relative level of Vimentin protein (to a β-actin 
loading control) across 3 experimental immunoblotting replicates. .Lines indicate where a T-
test has demonstrated a statistically significant difference in protein level. ** = P < 0.005.  
 
 
As Figure 11 shows, The sub-confluent SW480/Lamin A cells had a statistically 
significant higher level of expression of Vimentin compared to confluent 
SW480/Lamin A cells (P=0.002) and also compared to SW480/Control cultures 
that were sub-confluent (P=0.001). The greatest level of Vimentin expression 
was seen in the SW480/Lamin A cells at low cell density. The sub-confluent and 
confluent SW480/control cells expressed a lower level of Vimentin and this 
expression did not significantly change depending on cell density. 
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3.6: Slug expression  
 
As the molecular weight of Slug (36 kDa) is similar to β-Actin (35kDa), a GAPDH 
(25kDa) protein loading control was used instead. Densitometry analysis of 
samples from both loading controls indicated similar levels of protein were 
found in the same samples (Table 9), indicating that the use of GAPDH instead 
of β-actin in this instance should not affect the use of this loading control to 
standardize for variations in the starting levels of protein in the 4 samples, and 
in particular in the sub-confluent SW4890/Lamin A cells (LS), where significantly 
less starting protein was observed in all of the experiments. 
 
 
 
 
 
 
 
 
Figure 12: Immunoblotting of the transcription factor Slug using a Slug antibody with GAPDH 
as a loading control across 3 experimental replicate 
 
As Figure 12 shows, a protein band was seen at 36kDa indicating Slug 
expression in the sub-confluent SW480/Lamin A cells. A very faint band was 
seen in the SW480/Lamin A confluent cells. In the SW480/Control cells a faint 
band was seen in the sub-confluent cultures and a number of slightly darker 
bands around the 36kDa mark in the confluent SW480/Control cultures. As a 
number of bands were present in the SW480/Control cultures, this suggests 
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some non-specific binding of the Slug anti-body to the membrane and thus in 
the densitometry quantifications only the band at the 36kDa mark was 
analysed. 
 
 
   
 
Figure 13: A Graph showing the average relative levels of expression of Slug across 3 
experimental immunoblotting replicates. Lines indicate where a T-test has demonstrated a 
statistically significant difference in protein level.  
 * = P < 0.05 
 
As Figure 13 shows, the sub-confluent SW480/Lamin A cells (LS) had statistically 
significantly more Slug expression than confluent SW480/Lamin cells (P= 0.021) 
and sub-confluent SW480/Control cells (P=0.005).Once normalized against the 
β-Actin loading control, the sub-confluent SW480/Lamin A cells had the 
greatest level of Slug expression overall. In the SW480/Control cultures Slug 
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expression was marginally increased in the confluent cultures compared to the 
sub-confluent cultures but this result was not statistically significant. 
Table 9: Densitometry analysis of Loading control bands. As in above data, LS- sub-confluent 
SW480/Lamin A, LC- confluent SW480/Lamin A cells, GS- sub-confluent SW480/control cells 
and GC- confluent SW480/control cells. Level of protein relative to the largest band (GS) is 
shown. 
 
Loading Control Sample LS Sample LC Sample GS Sample GC 
Β-Actin 0.68 0.96 1.00 0.99 
GAPDH 0.68 0.96 1.00 1.00 
 
 
Table 10: A summary of the P values generated when using a paired T-test to compare 
protein expression in SW480/Lamin A sub-confluent to SW480/Lamin A confluent cultures. 
 
Protein Expression P Value 
Lamin A P: 0.011 
Vimentin P: 0.002 
Slug P:0.021 
 
Table 11: A summary of the P values generated when using an un-paired T-test to compare 
protein expression in sub-confluent SW480/Lamin A cells compared to sub-confluent 
SW480/Control cells. 
 
Protein Expression P Value  
Lamin A P:0.001 
Vimentin P:0.001 
Slug P:0.005 
 
As the P Value’s in Table’s 9 and 10 show, the expression of Lamin A, Vimentin 
and Slug was significantly higher in the SW480/Lamin A cells when they were 
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sub-confluent (at low cell density) compared to the same cell line at confluency 
(Table 9). The level of expression firstly of Lamin A was statistically greater in 
the sub-confluent SW480/Lamin A cells compared to the sub-confluent 
SW480/Control cells as were the levels of Slug and Vimentin. 
 
3.7: Chapter Discussion 
 
In a culture environment, the motile behaviour of a cell has been shown to be 
dependent on whether it is able to form contacts with neighbouring cells or 
whether it is free to move within the surrounding environment, thus cell 
confluency, or density, is an important director of cell motility (Persson et al., 
2010). The cell lines selected for these experiments, SW480/Lamin A and 
SW480/Control cells, allowed us to assess how Lamin A expression affected the 
expression of mesenchymal proteins at varying cellular densities due to the fact 
the SW480/Lamin A cells had significantly more Lamin A expression than the 
SW480/Control cells  at low cell densities as shown in Figure 9. 
 
At sub-confluence, epithelial cells can employ the use of Vimentin and Actin 
cytoskeletal filaments in order to move within their environment. As the cells 
reach confluence, Vimentin expression is down-regulated and replaced by 
Keratin filament expression that allows the formation of cell junctions. The 
expression of cytoskeletal filaments has also been shown to be dependent on 
the density of cells in 2D cultures. In freshly plated bovine pulmonary micro-
vascular endothelial cells, cytokeratin expression is initially observed as being 
disorganized and “hazy” at sub-confluence. With time, the Keratin forms 
plaques at cell junctions and eventually forms filaments in confluent cells. The 
assembly of the Vimentin filament cytoskeleton, also present in the cells at sub-
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confluency, is shown to decrease as the cells reach a more confluent state 
although the levels of expression of the protein may or may not change. This 
demonstrates how confluency may dictate the arrangement cytoskeletal 
proteins within cultured cells (Alexander et al., 1991). 
 
These experiments show that at sub-confluence in the SW480/Lamin A cells, 
endogenous Lamin A expression is greater compared to at confluence and thus 
Lamin A expression is affected by cellular density in these cells, when there is 
potential for motility and an absence of cell-cell contacts. 
 
The levels of GFP-Lamin A were not considered along with the levels of 
endogenous lamin A in these experiments. Changes in the expression of 
endogenous Lamin A in sub-confluent and confluent cells transfected with GFP-
Lamin A has been previously shown to be significant (Foster, 2011- e thesis, 
page 57).  By not considering the levels of GFP-Lamin A in all of the cultures 
tested this experiment has limitations on how accurately we can draw the 
conclusion that the endogenous Lamin A is responsible for the observed 
changes in Slug and Vimentin expression is SW480/Lamin A cells at low cell 
densities as the contribution of GFP-Lamin A was not quantified. A more 
detailed future study should consider how the expression of GFP-Lamin A and 
endogenous lamin A together in the SW480/Lamin A cells could modulate the 
expression of the 2 other proteins included in this study- Slug and Vimentin. 
 
The levels of the expression of the proteins Slug and Vimentin in the 
SW480/Lamin A cells at sub-confluence are also greater compared to the same 
cells at confluence (Table 9). As Slug and Vimentin are both markers of 
mesenchymal cells (Kalluri and Weinberg, 2009), this suggests that sub-
55 
 
confluent SW480/Lamin A cultures show evidence of being more mesenchymal 
in comparison to their confluent counterparts. Upon reaching confluence, the 
expression of Lamin A, Vimentin and Slug is reduced in the SW480/Lamin A 
cells, indicating that the up-regulated expression of the two mesenchymal 
markers and Lamin A itself in SW480/Lamin A cells is transient and appears to 
be dependent on cell density.  
 
These changes appear to be a result of the expression of Lamin A in SW480 
cells, as the levels of Lamin A, Vimentin and Slug were significantly higher in 
sub-confluent SW480/Lamin A cells compared to sub-confluent SW480/Control 
cells, which do not express Lamin A (Table 10), thus indicating a relationship 
between Lamin A, Vimentin and Slug expression. 
 
Experiments in cell culture environments using MCF10 breast cancer cells have 
shown that these cells can undergo spontaneous morphologic and phenotypic 
changes associated with EMT at low cell density. These changes include an up-
regulation in the transcription factor Slug and a spindle shaped morphology of 
cells that disappears as they become confluent (Sarriό et al., 2008). Experiments 
testing the effect of cell confluency on TGFβ1 induced EMT in cultured tubular 
epithelial cells show that TGFβ is unable to induce EMT in confluent monolayers 
of cells. Upon wounding of the cells, growth at sub-confluence or contact 
disassembly by Ca 2+removal this effect was reversed, thus indicating the 
importance of a low cell density in the induction of EMTs in cultured cells.  
 
Slug is a well-known repressor of the cell-junction protein E-cadherin (Yilmaz 
and Christofori, 2009) and various studies where Slug has been over-expressed 
in epithelial cells have shown them to adopt a mesenchymal phenotype (Medici 
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et al., 2008; Yilmaz, 2009). Connacci-sorrell et al. (2003) have shown an 
induction of Slug expression in SW480 cells at low cell density by β-Catenin-Tcf 
complex transcriptional activation or through the ERK signaling pathway.  Once 
the SW480 cells were grown to confluency, they formed an epithelial-like sheet, 
with β-catenin localized to adherens junctions.  
 
The data here indicate a similar induction in Slug expression in sparse cultures 
of SW480/Lamin A cells, but in this case the induction of Slug expression 
appears to have been mediated by the expression of Lamin A instead of 
modification to either the β-Catenin or ERK signaling pathways. 
The SW480 cell line typically expresses E-cadherin and β-catenin and lacks 
expression of Vimentin (Buck et al., 2007). The greater levels of expression of 
Vimentin in sparse cultures of SW480/Lamin A cells thus suggests that Lamin A 
may also be able to induce the expression of Vimentin when cells are unable to 
form contacts. There is an abundance of information reporting the importance 
of the Vimentin cytoskeleton in the behavior of motile cells. Studies using 
knock-out mice have demonstrated a reduced migratory capacity in epithelial 
cells that do not express Vimentin (Eckles et al., 2000). Within the context of 
cancer, Vimentin can be used as a biomarker for epithelial cell invasiveness in 
both prostate and breast cancers (Lang et al., 2002; Gilles et al., 1999). A study 
looking at Vimentin expression in malignant glioma cells at low density treated 
with chemotherapeutic agents has also indicated a correlation between high 
Vimentin expression at low cell density as a marker of invasive cells during 
chemotherapeutic treatment (Trog et al., 2008). Higher levels of Vimentin in 
sparse cultures of SW480/Lamin A cells thus suggests they may be more 
invasive than their control counterparts. 
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Together these results provide preliminary evidence that Lamin A expression in 
SW480 cells provides a signaling environment that allows EMT to occur in 
sparse cultures of SW480/Lamin A cells, demonstrated by a significant increase 
in the levels of Slug and Vimentin in these cells at low cell density in the 
presence of increased Lamin A expression. 
 
Judgement of the confluency of cells in culture can lead to variation, thus 
making the standardization of a 50% confluent cell culture difficult in between 
experimental replicates. A more detailed future analysis may therefore consider 
using cellular counting as a method for standardizing confluency, whereby sub-
confluent flasks should have a fixed percentage of fewer cells such as 50% of 
the number of cells of confluent samples. In this experiment eye-based 
judegments of confluency could have lead to potential experimental error, 
given that the level of confluency between cell cultures may vary. A sample 
taken from a sub-confluent cell population generally yielded less protein, due to 
the presence of fewer cells. This was overcome to an extent by using multiple 
growth flasks of cells for sub-confluent samples, but it was still difficult to 
obtain an equal amount of protein in the sub-confluent SW480/Lamin A sample 
compared to the other samples. The reasons for this are not known but may be 
due to the fact that the extra Lamin A in sub-confluent cells caused phenotypic 
and structural changes within these cells that made protein extraction using an 
SDS buffer more difficult. 
 
Immunoblotting as a quantitative technique also offers several limitations. The 
level of protein that was extracted from sub-confluent samples of the 
SW480/Lamin A cells was poor, hence resulting in a faint band in loading 
control experiments. As the loading control is used as a standard when 
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determining the relative levels of expression of proteins, the presence of a faint 
band could be a cause for error, as the analysis using densitometry is 
dependent on the area of the band and its mean gray value. Therefore, with 
smaller bands, the small level of background that may be incorporated into the 
densitometry value will cause a more significant experimental error in 
comparison to the larger bands. Nonetheless, given that this sample was able to 
demonstrate a significant level of both Lamin A and Vimentin expression 
despite the apparently low protein level, evidence is provided in favour of the 
conclusion drawn from the data that the levels of Lamin A protein and Vimentin 
protein were higher in the SW480/Lamin A cells compared to the 
SW480/Control cells.  
 
The quality of both the Vimentin and Lamin A/C antibodies was consistently 
good. The Slug antibody often resulted in some non-specific binding of the 
antibody to the membrane, demonstrated by a grey appearance in each lane. 
This may be due to the fact that it is more difficult to probe for low expression 
level proteins, such as transcription factors, in comparison to cytoskeletal 
proteins and nuclear lamina proteins.  
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Chapter 4: Scratch wound assays results 
 
4.1: Background and experiment aims  
 
Having observed high levels of expression of the mesenchymal-associated 
proteins  Vimentin and Slug in SW480/Lamin A cells at low cells density 
compared to at high cell density, scratch wounding assays were carried out on 
SW480/Lamin A cells to observe whether they displayed any mesenchymal 
properties in a scratch-wound environment. By creating a wound down the 
centre of a layer of confluent cells, a gap is created in which cells are free to 
migrate. This assay allows the study of cellular motility and behaviour the form 
of an in vitro study of cancer cell metastasis as the wounding of a layer of 
confluent cells can roughly mimic a tumour environment, where cells on the 
edges of a primary tumour may detach and migrate away from the tumour 
(Cory, 2011; Hulkower and Herber., 2011). Immunofluorescence was used to 
investigate the transcription factor Slug, the cell junctional protein E-cadherin 
and the cytoskeletal intermediate filament protein Vimentin. TRITC-conjugated 
phalloidin, a toxin that binds F-actin was used to observe changes in the actin 
cytoskeleton.  
 
SW480/Lamin A cells and SW480/Control cells were grown to confluence on 
glass coverslips before being scratch wounded. Confocal imaging of 
immunofluorescent staining was used to observe the levels and organisation of 
EMT proteins in SW480/Lamin A cells compared to controls to determine what 
effect Lamin A expression has on the expression of classical EMT markers in 
SW480 cells. 
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4.2: E-cadherin repression 
 
 
 
Figure 14: SW480/Control (rows 1 and 2) and SW480/Lamin A (rows 3 and 4) cell cultures 
that have been stained with an E-cadherin primary antibody and a TRITC conjugated 
secondary antibody. Rows 1 and 3 represent confluent cultures and rows 2 and 4 represent 
the edges of scratch wounds. White arrows indicate the presence of cell junctions in 
SW480/Control cultures. Yellow arrows indicate the absence of cell junctions in 
SW480/Lamin A cultures- even in areas of high cell density.  
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The cell adhesion molecule E-cadherin, which forms complexes at epithelial cell 
junctions, is primarily responsible for the maintenance of epithelial tissues.  
Repression of the E-cadherin gene promoter is a pre-requisite for cancer cell 
dissemination and EMT (Mahmut and Yilmaz, 2009). Dense cultures of SW480 
cells have been reported to have high level of E-cadherin expression at 
adherens junctions and to resemble an intact epithelium (Conacci-Sorrell et al., 
2003). The induction of Slug expression through β-catenin signaling has been 
shown to induce the repression of E-cadherin and dissolution of cell-cell 
contacts at the adherens junctions of SW480 cells and thus cell density 
dependent relationship between Slug expression and E-cadherin repression in 
SW480 cells has been previously been established (Conacci- Sorrell et al., 2003). 
 
Confluent cultures of both SW480/Lamin A cells and SW480/ Control cells were 
fixed following scratch wounding and stained with an E-cadherin antibody 
conjugated to TRITC. The results were visualized by confocal microscopy. As 
seen in Figure 14, the SW480/Lamin A cells are clearly distinguishable from the 
SW480/Control cells due to the peri-nuclear presence of GFP-Lamin A, shown in 
the GFP channel. The SW480/Control cells had diffuse, lower levels of GFP in 
this experiment that were not as easy to detect. The SW480/Lamin A cells 
showed background expression levels of E-cadherin (rows 3 and 4). This 
occurred both in areas of high density and also in cells at the edges of the 
scratch wounds. Cell junctions were largely absent from SW480/Lamin A cells 
regardless of their confluency.  
 
 In contrast, the SW480/Control cells are able to form junctions in areas of cell 
confluence at the centre and edges of scratch wounds (Figure 14). This data 
suggests that expression of Lamin A in SW480 cells may repress the expression 
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of E-cadherin and leads to loss of cell adherens junctions, shown by a lack of 
expression of E-cadherin in confluent SW480/Lamin A cells (yellow arrows-
Figure 14). 
 
4.3: Slug expression 
 
 
 
Figure 15: SW480/Control (rows 1 and 2) and SW480/Lamin A cells (rows 3 and 4) that have 
been stained with a Slug primary and a TRITC conjugated secondary antibody. Rows 1 and 3 
represent confluent cultures and rows 2 and 4 represent the edges of scratch wounds. GFP-
Lamin A expression is represented in column 2- GFP.  White arrows indicate increased 
nuclear Slug in SW480/Lamin A cells in both confluent cells (row 3) and in particular, at the 
edges of scratch wounds (row 4). 
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Slug is a Zinc-finger transcription factor that binds the E-cadherin promoter 
within the nucleus, repressing its transcription (Harjra et al, 2002), and is an 
important inducer of EMT (Hoshino et al., 2011. As shown in Figure 15, Slug 
expression was mostly absent in the SW480/Control cells at both the edges of 
the scratch wounds and at the centre of the epithelial sheet.  
 
In contrast there was extensive expression of Slug (both cytoplasmic and 
nuclear) in the SW480/Lamin A cells, which was most prominent in cells at the 
edges of the scratch wounds (row 4). The expression of nuclear Slug increased 
in the SW480/Lamin A cells at the edges of scratch wounds (white arrows-row 
4), where nuclear “speckles” of Slug protein were present in the nuclei of the 
SW480/Lamin A cells. The most consistent cellular staining occurred in the peri-
nuclear and nuclear regions of the SW480/Lamin A cells at both the centre and 
edges of the scratch wounds (shown by white arrows in rows 3 and 4- Figure 
15). The increased expression of Slug in the SW480/Lamin A cells did not appear 
to be solely an effect of the levels of GFP-Lamin A in these cells. This is shown 
by the fact that cells with lower levels of GFP-Lamin A (yellow arrow, GFP 
channel- row 4, Figure 15), still had high levels of Slug (yellow arrow, TRITC 
channel- row 4, Figure 15). As previously mentioned, transfection of the SW480 
colorectal cancer cells with the GFP-Lamin A also significantly increased the 
expression of endogenous Lamin A (Foster, 2011- PhD thesis) and therefore the 
observed increase in Slug in the SW480/Lamin A cells may also be due to the 
increase in endogenous Lamin A in these cells. 
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4.4: Filamentous Actin expression 
 
 
 
Figure 16: SW480/Control (rows 1 and 2) and SW480Lamin A cells (rows 3 and 4cells stained 
with TRITC-phalloidin which stains filamentous actin. Rows 1 and 3 represent confluent 
cultures and rows 2 and 4 represent the edges of scratch wounds. White arrows indicate 
cortical actin bundles typical of epithelial cells in SW480/Control cultures. Yellow arrows 
indicate lamellipodium formation in SW480/Lamin A cells. 
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Re-organization of the actin cytoskeleton is an important part of the EMT 
process as it is a major determinant of cell shape and polarity (Yilmaz and 
Christofori., 2009).  To determine whether there were changes in the actin 
cytoskeletons of scratch wounded SW480/Lamin A cells, cells were stained with 
a TRITC-conjugated actin filament binding toxin phalloidin.  
 
SW480/Lamin A cells had a different cellular shape compared to SW480/Control 
cells. The SW480/Control cells had a “cobblestone-like” appearance in the 
epithelial sheet but were more rounded at the wound edge. In contrast the 
SW480/Lamin A cells were elongated and spindle-like in confluent cells at the 
centre of the culture and at the wound edge. In SW480/Control cells, actin 
expression was concentrated at the cytoplasmic edges of the cells, and was 
organized into thin cortical bundles at the cell boundaries which is consistent 
with its organization into epithelial sheets (Haynes et al., 2011 ;Doherty and 
McMahon, 2008). The SW480/Control cells at the edges of the scratch wounds 
did not vary drastically from the cells in the centre of the epithelial sheet except 
for some evidence of filipodia formation (shown by white arrow in Figure 16-
row 2).  
 
In SW480/Lamin A cells phalloidin staining was not concentrated at cytoplasmic 
edges but was more diffuse through the cytoplasm with some evidence of 
perinuclear staining. This altered staining is consistent with increasing motility 
as increased tethering of the Actin cytoskeleton to the nucleus through the LINC 
complex is important in cellular movement (Chambliss et al., 2013). At the 
edges of the scratch wounds, the formation of lamellipodia and spreading of 
the cell membrane was also observed in SW480/Lamin A cells (Yellow arrows).  
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4.5: Vimentin expression 
 
 
 
Figure 17: SW480/Control(rows 1 and 2)  and SW480Lamin A cells (rows 3 and 4) that have 
been stained with a TRITC-conjugated Vimentin antibody.- Rows 1 and 3 represent confluent 
cultures and rows 2 and 4 represent the edges of scratch wounds. White arrow shows 
background levels of Vimentin staining at the edge of the scratch wound in SW480/Control 
cultures. Interestingly one of the SW480/Control cultures expressed high levels of GFP (White 
arrow- row 2, GFP channel) Yellow arrows indicate significant peri-nuclear Vimentin 
expression.in SW480/Lamin A cells.  
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Expression of Vimentin was largely absent in SW480/Control cells (rows 1 and 2 
Figure 17). In contrast the SW480/Lamin A cells displayed uniform expression of 
Vimentin in both the cells at the confluent centre and edges of scratch wounds.  
Increased Vimentin expression was more dramatic at the edge of the scratch 
wounds (Yellow arrows in Figure 17). In these cells Vimentin appeared to be 
organized into cytoskeletal filaments which were dense in peri-nuclear areas 
before radiating out along the cell axis. The SW480/Lamin A cells showed 
varying levels of GFP-Lamin A (rows 3 and 4- GFP channel) but the increases in 
Vimentin staining compared to the SW480/Control cells were mostly consistent 
across the cellular populations shown in the fields imaged (rows 3 and 4 –TRITC 
channel) 
 
4.6: Chapter discussion 
 
Using confocal microscopy SW480/Lamin A and SW480/Control cultures have 
been visualized at the edges and centres of scratch wounds with the aim of 
observing the expression of classical EMT markers.  
 
The cell junction protein E-cadherin is tethered to actin filaments by a series of 
proteins including β-Catenin. As E-Cadherin maintains the integrity of an 
epithelium through its connections via adherens junctions, the dissolution of 
cell-cell contacts through repression of E-Cadherin expression also leads to 
wide-spread changes in configuration of the actin cytoskeleton that allow it to 
direct cell motility (Yilmaz and Christofori, 2009). Willis et al (2008) have 
previously shown that SW480/Lamin A cells have down-regulated E-cadherin 
expression using RT-PCR and this was visualized at the level of protein 
expression in SW480/Lamin A scratch wound assays. 
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Previously microarray analysis on SW480/Lamin A cells has shown an increase 
in the level of Slug mRNA in comparison to SW480/Control cells (Foster 2011, 
PhD thesis). As mRNA data suggesting an up-regulation in gene expression does 
not always necessarily lead to a linear increase in functional protein expression, 
due to potential mRNA degradation or poor protein folding (You and Yin, 2000), 
these immunofluorescent experiments demonstrate an important increase in 
Slug at the protein level in SW480/Lamin A cells. The zinc finger transcription 
factor Slug behaves as a repressor of E-cadherin expression by binding to the E-
cadherin gene promoter, ultimately causing Histone modifications such as 
hyper-methylation. The result is epigenetic silencing of the gene (Bolόs et al., 
2002). In the absence of E-cadherin, β-Catenin is released into the cytoplasm, 
where it can traverse into the nucleus and activate the Wnt signalling pathway 
by interaction with members of the Tcf/Lef family of transcription factors. This 
causes changes in expression of a large number of genes involved in cellular 
adhesion, migration, invasion and morphogenesis (Wong and Pignatelli., 2002). 
For these reasons Slug is a well-known inducer of the EMT process, which has 
been demonstrated in a number of different cancer cell lines, including oral 
(Joseph et al., 2009), pancreatic (Zhang et al., 2011) colon (Camp et al., 2011) 
and breast (Vuoriluoto et al., 2011). Slug is also as a marker of poor patient 
prognosis in many human cancers (Peinado et al., 2007). Slug expression was 
up-regulated in SW480/Lamin A cultures, particularly in nuclear regions. This is 
a second indicator of a more aggressively motile phenotype in SW480/Lamin A 
cells and due to the location of the Slug staining, suggests that Slug may be 
acting on the E-cadherin promoter region in SW480/Lamin A cells to repress E-
cadherin protein expression. Future work should look to identify whether Slug is 
acting alone to repress E-cadherin, or whether other commonly identified 
repressors, such as Snail, ZEB1 and Twist  (Kalluri and Weinberg, 2009) could 
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also be responsible for the observed dissolution of cellular junctions in 
SW480/Lamin A cells that is a crucial part of the EMT process. 
 
Previously Willis et al (2008) found an up-regulation in expression of the actin-
bundling protein T-Plastin, which is a protein commonly associated with 
invasive and metastatic cells.  Foster et al (2011) subsequently demonstrated an 
increase in the levels of filamentous actin in SW480/Lamin A cells. Here, 
filamentous actin, which is associated with cells of greater metastatic potential 
(Nowak et al., 2002), was visualized in SW480/Lamin A cells in these 
immunofluorescent experiments. The cells showed significant changes in the 
arrangement of the actin cytoskeleton compared to SW480/Control cells that 
indicated a more motile phenotype, including lamellipodia formation at the 
edges of scratch wounds. The formation of a lamellipodium is a pre-requisite 
for cell movement across a 2D planar surface (Yamaguchi and Condeelis., 2007) 
so  the observed formation of these structures at the edges of scratch wounds 
suggests that these cells were moving into the area of  free space created. 
Change in cellular shape from a regular, “cobblestone” epithelial- type shape to 
a mesenchymal-like fibroblastic shape were also observed which were similar to 
those recorded by other groups using  TGFβ–induced EMT on epithelial cells 
(Miettinen et al., 1994; Haynes et al., 2011; Kalluri and Weinberg, 2009). Very 
elongated cells also displayed the formation of thick stress-fibres, ventral to the 
cell surface, which ran along the cell axis. These fibres could contribute to 
cellular contraction in order to allow motility, given that contractile stress-fibre 
formation is also a pre-requisite for cell movement (Xu et al., 2009; Haynes et 
al., 2011). 
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Foster (2011) has previously demonstrated that SW480/Lamin A cells express 
more Vimentin using proteomic analysis. An increase in Vimentin expression 
was visualised for the first time here in the SW480/Lamin A cells using 
immunofluorescence. The type III intermediate filament is up-regulated in most 
cancers and like Slug, can be a marker of poor patient prognosis (Satelli and Li, 
2011). Increasingly, multi-functional roles for Vimentin in cellular adhesion, 
migration and signaling are being uncovered (Ivaska  et al., 2007;Satelli and Li, 
2011). Vimentin is an important signaling mediator in the EMT process (Ivaska, 
2011), has been shown to co-localize with Lamin A (Mergui et al., 2010). 
Recently the ability of Vimentin to functionally contribute to the EMT process 
was shown by Mendez et al., (2010), whereby transfection of epithelial cells 
with Vimentin caused an increase in mesenchymal morphologic and motile 
characteristics in the cells. 
 
The relationship between Vimentin expression and Slug expression has been 
studied in breast cancer where Vuoriluoto et al (2011), showed that ectopic 
expression of the EMT-inducing transcription factor Slug induces Vimentin 
expression and migration in pre-malignant epithelial cells. Vimentin expression 
was necessary for Slug-induced migration and the motile characteristic 
demonstrated by the cells. Using immunofluorescence, this group reported up-
regulation of both Slug and Vimentin at the wound edges of scratch wounding 
assays when the cells expressed Slug. The results also indicated important 
changes in the shapes of the epithelial cells that were transfected with Slug, 
whereby a more fibroblastic morphology was observed and the migratory 
capacity of the cells was increased. Finally, gene expression profiling carried out 
by the group has indicated a positive correlation between Vimentin expression 
and genes that contribute to invasiveness. The scratch wounding assays 
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performed here on colorectal cancer epithelial cells show strikingly similar 
results in terms of both an induction of Slug and Vimentin expression 
contributing to a more mesenchymal cellular phenotype, with observations of 
cells demonstrating the most invasive phenotypes at the edges of scratch 
wounds. This suggests that the two proteins may be working together in a 
larger signalling network involving the Lamin A protein and other potential 
signalling partners.  
 
Together the above results indicate a significant change in the SW480 cells from 
a less invasive, less motile epithelial cell type (SW480/Control) to a more motile, 
more invasive mesenchymal cell phenotype (SW480/Lamin A) as a result of 
stable transfection of Lamin A . There was clear variation in the levels of GFP-
Lamin A in the SW480 cells used in these experiments, where some 
SW480/Lamin A cells showed significantly more Lamin A signal in the GFP 
channel. As cells with less GFP-Lamin A still showed significant mesenchymal 
properties such as increased Vimentin and Slug expression, this suggests the 
changes observed could partly be due to the increased levels of endogenous 
Lamin A that have been observed previously in the SW480/Lamin A cells by 
western blot in this thesis (Chapter 3) and from previous work (Foster, 2011- 
PhD thesis). The induction of Slug and Vimentin expression, dissolution of cell-
cell contacts through E-cadherin repression and re-arrangement of the 
cytoskeleton, which are all present in SW480/Lamin A cells and not in 
SW480/Control cells gives substantial evidence of the occurrence of an EMT in 
the SW480/Lamin A cells. It thus appears that high levels of Lamin A expression 
in SW480 cells provides a suitable signaling environment for EMT to occur. Lui 
et. al (2013), have found that the de-regulated expression of the three proteins 
Vimentin, E-Cadherin and Slug correlated with poor clinical outcome in patients 
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with breast cancer. As the data shows here that expression of these three 
proteins is also increased in  scratch-wounded SW480/Lamin A cells, further 
confirmation is given towards the significance of the Lamin A protein as a risk 
biomarker in colorectal cancer (Willis et al., 2008), as it contributes to the 
production of a more aggressive cancer cell phenotype.   
 
In a scratch-wounding assay cells are cultured in a 2 dimensional environment. 
In vivo, cells are in a 3-dimensional environment and thus the assay has several 
limitations in terms of mimicking the EMT process in live tissue, as important 
properties that contribute to the EMT process such as cell adhesion and cell-cell 
signaling may be altered (Muthuswamy, 2011). Future studies may therefore 
consider observing Lamin A expressing SW480 cells in artificial 3-dimensional 
cultures to observe their cell shape, levels of expression of Slug, Vimentin and 
E-cadherin and arrangement of the cytoskeleton in an environment that more 
closely mimics a real adenocarcinoma to determine whether SW480 cells are 
still able to display the mesenchymal characteristics that have been observed in 
these 2-Dimensional experiments. 
 
 
 
 
 
 
 
 
 
 
73 
 
Chapter 5: siRNA knockdown results 
5.1: Background and aims 
 
In the previous chapter, SW480/Lamin A cells have demonstrated an up-
regulation in Vimentin and Slug expression, repression of E-Cadherin expression 
and a re-organization of the actin cytoskeleton using immunofluorescence. This 
gives further evidence that Lamin A is able to induce mesenchymal 
characteristics in SW480 cells. Lamin A silencing experiments in SW480/Lamin A 
cells were therefore performed to determine whether the cells express these 
mesenchymal markers in the absence of Lamin A expression. The siRNA used in 
this experiment has been custom-produced and optimized by Foster (2011- PhD 
thesis). The oligonucleotide targeted exons 11 or 12 of the post-transcriptional 
products of the LMNA gene, thus making it specific for the Lamin A protein and 
not Lamin C (given that the two proteins are alternatively spliced products of 
the same gene).  
 
5.2 Confirmation of Lamin A silencing  
 
Silencing of Lamin A protein expression was confirmed using western blotting. 
Samples for western blotting were prepared from T25 cm3 cell culture flasks 
containing cells subjected to siRNA treatment. Immunoblotting was performed 
using a Jol2 antibody with β-actin used as a loading control at successive time 
points of 48, 96, 120 and 144 hours. As Figure 18 shows, silencing of 
endogenous  Lamin A was effective from 48h to 144h after initial transfection of 
cell cultures with the oligonucleotide. This is demonstrated by the faint bands 
at 75kDa in the “si” samples. The faintest bands were seen between 96 and 120 
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hours after transfection, which indicates where the knockdown was most 
effective. The siRNA knockdown was less effective at reducing the expression of 
GFP-Lamin A, where expression levels appeared to be maintained at the same 
levels as the control samples across all time points. 
  
 
 
 
 
 
 
 
 
Figure 18: Western blotting of whole cell lysates prepared from SW480/Lamin A cells that 
have been transfected with siRNA targeting the Lamin A gene (si) and scrambled siRNA (cntl). 
Bands at 100kDa represent GFP-Lamin A. Bands at 75kDa represent Lamin A and the bands 
underneath are Lamin C. Bands at 35kDa represent β-actin. 
 
Immunofluorescent experiments were then performed on cells in 6 well plates 
that had been subjected to 96h to 144h of siRNA transfection. 
Immunofluorescence microscopy revealed that Lamin A knockdown caused 
structural changes to the nucleus, shown by the increased presence of 
shrunken, dysmorphic nuclei. Although not shown consistently in the Western 
analysis, effective knockdown of GFP-Lamin A may have occurred in some cells 
where GFP expression was significantly reduced within the region of the nuclear 
lamina. These cells were targeted for analysis, given that they demonstrated 
Lamin A repression to some degree.  Cells demonstrating successful Lamin A 
knockdown occurred in small groups within the seeded cultures, suggesting 
 
- 75kDa  
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- 35 kDa  
48h 144h 120h 96h 
si cntl si cntl cntl si 
 
cntl si 
75 
 
multiple divisions of cells successfully transfected with the siRNA. 
 
5.3: Vimentin expression  
 
 
 
Figure 19: 70% confluent SW480/Lamin A cell cultures that have been subjected to 
transfection with scrambled siRNA (Control-row 1) and siRNA targeting the transcriptional 
products of the LMNA gene (si Lamin A- rows 2 and 3). All cells are stained with a Vimentin 
antibody. White arrows indicate limited Vimentin cytoskeleton formation in si Lamin A cells. 
Yellow arrows indicate the presence of shrunken and dysmorhic nuclei in si Lamin A cells. 
 
The effect of Lamin A knockdown on the Vimentin cytoskeleton (TRITC channel- 
Figure 19) was seen most markedly at 144 hours, where Vimentin expression 
was shown to be greatly reduced. Although western blotting experiments show 
that Lamin A knockdown is most effective at 120h, the most significant 
observed reduction in Vimentin cytoskeleton expression seen using 
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immunofluorescent microscopy was at a later time period. This may be due to 
the stable nature of intermediate filaments and signalling changes that would 
have occurred in order for an initial reduction in Lamin A expression to have an 
effect on the Vimentin cytoskeletal networks present in the cells. In the si Lamin 
A cells, knockdown of the GFP-Lamin A was variable. Vimentin expression was 
reduced in all of the cells transfected with the siRNA however, suggesting that 
the decrease in Vimentin may be partly due to decreases in the endogenous 
Lamin A seen in the western analysis in Figure 18. Sparse expression was 
maintained in the peri-nuclear areas of the cells (white arrows). There was a 
significant reduction in the number of filaments seen in the cytoplasm in 
comparison to the control cells, where strong staining was observed for 
Vimentin.  
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5.4: Filamentous Actin expression 
 
 
Figure 20: SW480/Lamin A cultures that have been transfected with scrambled siRNA 
(Control- row 1) and siRNA targeting the Lamin A gene (si Lamin A- rows 2 and 3) for 120 
hours. All cells have been stained with TRITC phalloidin. White arrows indicate a change in 
cell architecture in the si Lamin A cells, where cells have become more rounded, with 
reduced adherence to the surface substrate. 
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siRNA knockdown of Lamin A caused significant changes in the organisation of 
actin cytoskeletons of the SW480/Lamin A cells at 120 hours. Changes in the 
shape of the cells from a flattened and spindle-like, morphology to a more 
rounded and cobble-stone shaped morphology was observed in cells that 
underwent successful lamin A knockdown. The prominent stress fibre formation 
seen in in the control cultures was not observed in cells that were transfected 
with the siRNA that targeted Lamin A (si Lamin A cells). si Lamin A cells also 
demonstrated collapse of the cytoskeleton towards the nucleus and 
detachment from the surface substrate (white arrows). Control cells maintained 
a flattened morphology with extensive actin cytoskeletal filaments maintained 
in the cytoplasm. Overall the effect of transfection of siRNA against the Lamin A 
gene had variable effects on the actin cytoskeleton, with some cells remaining 
flattened and spindle-like (yellow arrow) but others demonstrating a more 
rounded, epithelial cellular architecture. (white arrows).  
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5.5: Slug expression 
 
 
Figure 21: SW480/Lamin A cultures that have been transfected with scrambled siRNA 
(Control- row 1) and siRNA targeting the Lamin A gene (si Lamin A- rows 2 and 3) for 120 
hours. All cells have been stained with a Slug antibody. Yellow arrows indicate an absence of 
nuclear Slug in si Lamin A cells that have undergone Lamin A knockdown, shown by an 
absence of signal in the GFP channel (shown by white arrows). 
  
 
The expression of Slug was variable in SW480/Lamin A cells that had undergone 
silencing of Lamin A with most effective knockdown occurring between 120h 
and 144h. Cells demonstrating the most successful Lamin A knockdown, shown 
by a marked decrease in the presence of GFP-Lamin A, also demonstrated 
significantly reduced levels of Slug. This reduction was most prominent in the 
nucleus, where staining was almost absent (yellow arrows in Figure 3.4). Other 
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cells, where knockdown had been less effective, maintained some nuclear 
expression of Slug In control experiments expression of Slug was uniformly 
maintained in the nuclei of the SW480/Lamin A cells, where staining was 
observed to occur in small aggregates or “speckles” as previously observed.  
 
5.6 Fibronectin expression 
 
As the previous Chapter 3 has indicated an increase in the levels of expression 
the mesenchymal markers Slug and Vimentin in the SW480/Lamin A cells at low 
cell density, and Chapter 4 has shown that these markers are increased in the 
SW480/Lamin A cells in a scratch wounding environment, a further 
confirmation of a mesenchymal phenotype in the SW480/Lamin A cells would 
complement these results. Fibronectin is another robust marker of 
mesenchymal cells (Kim et al, 2013) and was therefore selected to further 
complement previous analyses.  
 
Figure 22: SW480/Lamin A cultures that have been transfected with scrambled siRNA (si 
Control- row 1) and siRNA targeting the Lamin A gene (si Lamin A- row 2) for 120 hours. All 
cells have been stained with a fibronectin antibody.  
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As Figure 22 shows, there was a marked reduction in Fibronectin expression in 
the si Lamin A cells shown by a reduction in red cytoplasmic staining in the 
siLamin A cells. 
 
5.7: Chapter Discussion 
 
RNA interference (RNAi) is a method in which transfection of a cell with short 
double stranded oligonucleotides results in the nuclease-induced destruction of 
mRNAs of the target gene and as a result, reduced expression of protein(s) 
encoded for by the gene, which is known as Post transcriptional gene silencing 
(PTGS) (Bernstein et al., 2000). Here, PTGS of the Lamin A gene was achieved 
successfully, demonstrated by reduced expression of the Lamin A protein by 
western blotting analysis.  
 
The aims of these experiments were to consolidate our understanding of the 
relationships between Lamin A expression and expression of proteins Vimentin, 
Actin and Slug in relation to cell motility and invasive cellular behaviour.  
 
Lamin A knockdown in the SW480/Lamin A cells caused a decrease in the 
expression of Vimentin.  The role of Vimentin in both cancer and EMT has been 
discussed in chapter 4, where Vimentin was shown to be up-regulated in 
SW480/Lamin A cells using immunofluorescence. As silencing of Lamin A has 
decreased Vimentin expression, this suggests that Lamin A may regulate the 
expression of Vimentin through a signalling pathway. 
 
The observed decrease in Slug expression in cells that had undergone Lamin A 
gene silencing also suggests a relationship between Lamin A expression and 
Slug expression in the SW480/Lamin A cells.  Foster (2011, PhD thesis), has also 
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demonstrated that knockdown of Lamin A in the SW480/Lamin A cells results in 
a reduction in the expression of Slug mRNA using microarray analysis, but this is 
the first time that Lamin A silencing has been shown to reduce the expression 
of Slug at the protein level. Slug is a transcription factor that is a well-known 
inducer of EMT. It is known to promote cell motility and invasion in a number of 
different cancer cells (Park et al 2008; Hotz et al., 2007; Uchikado et al., 2005). 
In SW480/Lamin A cells that had undergone knockdown of Lamin A, Slug 
expression was almost absent in the nucleus, suggesting it did not behave as a 
transcriptional repressor of the E-cadherin promoter in the cells that were 
successfully silenced for Lamin A. 
 
 A relationship between Slug expression and Vimentin expression has been 
deduced in breast cancer (Vuoriluoto et al., 2011) where Vimentin is necessary 
for Slug-induced, EMT-associated migration. High Vimentin and high Slug 
expression is also associated with poor patient prognosis in Basal-Like Breast 
Cancer (Lui et al., 2013. As Slug expression can be induced through TGFβ 
signalling (Medici et al., 2008) and Lamin A can regulate TGFβ signalling (Van 
Berlo et al., 2005), future work could look to determine whether TGFβ signalling 
may be responsible for the Lamin A-dependent up-regulation of Slug and 
Vimentin expression in SW480/Lamin A cells.  
 
As knockdown will have compromised the regular structure of the nuclear 
lamina, it thus follows that the interactions Lamin A forms as part of the LINC 
complex, bridging the nucleus with the cytoskeleton, caused changes to the 
actin cytoskeleton and overall cell architecture (Meinke et al., 2011). Willis et al 
(2008) have previously shown using semi-quantitatice RT-PCR that knockdown 
of Lamin A in SW480/Lamin A cells significantly reduces their motility and the 
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levels of the actin-bundling protein T-Plastin.  Here the impact of  Lamin A 
knockdown on the Actin cytoskeleton was visualized. Knockdown caused the 
disruption of actin cytoskeleton networks and a reduction in the levels of 
filamentous actin in SW480/Lamin A cells. The reduction in stress fibre 
formation, along with changes in architecture and morphology suggests that 
knockdown in Lamin A in SW480/Lamin A cells causes them to adopt a more 
epithelial phenotype.  Extensive stress fibre formation and spindle-like 
morphology are typical hallmarks or mesenchymal cells (Haynes et al., 2011). As 
fewer cells demonstrated these characteristics in SW480/Lamin A cultures that 
were subjected to siRNA treatment, this suggests that the presence of Lamin A 
in SW480 cells contributes to a motile organisation of the Actin cytoskeleton, 
which is reversed upon Lamin A silencing.  
 
The observed reduction in fibronectin expression in the cells that had 
undergone Lamin A knockdown compared to the SW480/Lamin A control cells 
further suggests that Lamin A contributes to an mesenchymal phenotype in the 
SW480/Lamin A cells as this protein is a marker of mesenchymal cells and also 
of poor patient prognosis in cancer (Sudo et al., 2012).  Together, down-
regulated Fibronectin, Vimentin and Slug expression, coupled with the 
conversion of the Actin cytoskeleton to a more epithelial structure in the 
silenced cells show that in the absence of Lamin A, some of the mesenchymal 
properties previously observed in SW480/Lamin A cells in Chapter’s 3 and 4 are 
reversed and that silencing of Lamin A in SW480/Lamin A cells reduced their 
mesenchymal phenotype. 
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Chapter 6: Discussion 
 
The nuclear envelope (NE) is an important mediator of transcriptional control, 
cell polarity and migration, genomic stability and cell division. These cellular 
processes are often aberrant in a cancerous environment (Chow et al., 2012). 
The Lamin A protein, which is a multi-functional constituent of the nuclear 
lamina, forms part of the nuclear envelope. This protein has also been found to 
be aberrantly expressed in a variety of cancers (Foster, 2010). In the case of 
colorectal cancer, Lamin A has been found to be a risk biomarker. Willis et al 
(2008) have shown that patients with colorectal cancer tumours positive for 
Lamin A expression were almost twice as likely to die in comparison to 
clinicopathologically identical patients whose tumours did not express Lamin A.  
 
To explore why Lamin A expression lead to poor patient prognosis, the SW480 
pre-metastatic colorectal cancer cell line was stably transfected with a Lamin A-
GFP fusion protein. This significantly increased the motility of SW480 cells. 
Elucidation of the reasons behind this increase in motility has involved genomic 
and proteomic studies. Willis et al (2008) have shown that the increase in Lamin 
A expression in SW480 cells causes a change in the actin cytoskeleton and the 
adhesive properties of the cells. Further data produced by Foster (2011) 
showed futher changes in the cytoskeletal fractions of SW480/Lamin A cells 
that showed an increase in filamentous actin and Vimentin, which are both 
markers of a mesenchymal cell architecture.  
 
Ingenuity Pathways Analysis (IPA) analysis of microarray data allows us to 
deduce significant signaling networks by considering the simultaneous up and 
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down-regulation of several genes within an experiment. Microarray data 
recorded when SW480 cells were transfected with GFP-Lamin A to give 
SW480/Lamin A cells has been subjected to IPA analysis. The changes in the 
levels of the mRNA trascripts of a number of genes, including Slug and 
Vimentin,  gave evidence for the role of Lamin A in a signalling regulatory 
network contributing to an increased invasive and metastatic phenotype in 
SW480 cells. This data also showed an increase in the levels of TGFβ  mRNA and 
a down-regulation in E-Cadherin mRNA present in the SW480/Lamin A cells 
compared to SW480/Control cells transfected with GFP only. Furthermore, 
observations of the morphologies and behaviour of SW480/Lamin A cells using 
live cell imaging has indicated that the cells are typically mesenchymal in shape. 
It was thus speculated that an increase in Lamin A expression in SW480 
colorectal cancer cells may make them more amenable to undergo an EMT 
(Foster 2011, PhD thesis).  
 
The aims of this thesis were therefore to further understand how increased 
Lamin A expression in SW480 cells changes their cellular phenotype. Initially the 
effect of cell confluency in relation to expression of Lamin A, Vimentin and Slug 
was tested. Immunofluorescence was then used to look for changes in 
expression of EMT proteins in a scratch wound-assay. Finally siRNA knockdown 
of Lamin A was performed to determine whether this had any effect on the 
expression of proteins in relation to the EMT process.  
 
Immunoblotting experiments indicated that SW480/Lamin A cells demonstrate 
a mesenchymal phenotype that is prominent at low cell density, shown by an 
increase in Vimentin and Slug expression. This effect was Lamin A dependent, 
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as in the SW480/Lamin A cultures at high cell density, expression of Lamin A, 
Slug and Vimentin was reduced.  
 
Scratch wounding experiments show SW480 cells lack cell junctions and have 
high Vimentin and high Slug expression. Along with these mesenchymal cellular 
properties, the Actin cytoskeletons in SW480/Lamin A cells showed re-
arrangements necessary for cell motility.  
 
The contribution of Lamin A to the changes observed in the first 2 experiments, 
assessed by Lamin A silencing on SW480/Lamin A cells, caused the 
SW480/Lamin A cells to significantly down-regulate their Vimentin and Slug 
expression. The Actin cytoskeletons of silenced SW480/Lamin A cells also 
underwent morphologic changes that suggested a decrease in their motile 
phenotype and their fibronectin expression, a classical EMT marker, was 
reduced.  
 
This data has established an important link between Lamin A and Vimentin 
expression in SW480/Lamin A cells. The two proteins have been found to co-
localise in neuroblastoma tissue (Mergui et al., 2011) and furthermore, there 
has been recent recognition of the multi-functional importance of Vimentin, the 
type 3 intermediate filament, as both a structural and signalling protein like 
Lamin A.  Vimentin has been identified to have distinct roles in cell adhesion 
and migration ( Ivaska et al, 2007) and in the specific context of cancer, 
Vimentin behaves as a marker of aggressive breast cancer cell lines (Neve et al., 
2006) and of the EMT process (Yilmaz and Christofori, 2009).  In the proposed 
signaling EMT signaling pathway mediated by Lamin A in Figure 23, Vimentin is 
thus indicated as having effects on both cell motility and cell architecture, due 
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to the changes expression of this protein induces on both the shape of 
SW480/Lamin A cells and previous evidence of its roles in adhesion and 
migratory changes that allow cellular motility. Given the established roles for 
Vimentin in the context of many cancers, the observed relationship that the 
protein may share with Lamin A should be further elucidated. Future 
experiments should look to determine the effect of Vimentin knockdown on 
Lamin A expression in SW480/Lamin A cells, as this well allow further 
establishment of a signalling relationship between the two proteins. Vimentin 
has been shown to regulate ERK signalling, which is an important pathway in 
development and maintenance of cancers (Ivaska et al., 2007). ERK signalling is 
also able to induce the expression of Slug in SW480 cells (Connacci-Sorrell et al., 
2003), and thus would make an important future signalling pathway to study. 
 
The fact that high levels of Lamin A expression in SW480/Lamin A cells leads to 
high levels of Slug expression and vice versa could partly explain why colorectal 
cancer patients with high expression of Lamin A in their tumours can have a 
poor prognosis (Willis et al., 2008), as the potential expression of Slug in these 
tumours may contribute to a more motile and invasive phenotype of the 
colorectal cancer cells through the process of EMT. Slug has also been shown 
independently to be a marker of poor prognosis in colorectal carcinoma 
patients (Shioiri et al., 2006), thus demonstrating the implications for Slug 
expression as a contributor to more aggressive colorectal cancer cells. The up-
regulation in Slug protein expression occurred simultaneously with a significant 
down-regulation in E-cadherin expression, demonstrated by a lack of junctional 
formation in SW480/Lamin A cells, even in areas of high cell density. E-cadherin 
repression, along with an increase in expression of an EMT-inducing 
transcription factor such a Slug is one of the earliest pre-requisites for the 
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occurrence of EMT and thus shows that the process can be initiated in 
SW480/Lamin A cells. Vuoriluoto et al (2011) have shown that Slug induces the 
expression of Vimentin in breast cancer cells leading to a more invasive 
phenotype and therefore in Figure 23, Slug is indicated as an inducer of 
Vimentin expression. Slug is also indicated as inducing re-arrangements in the 
Actin cytoskeleton and repression of E-cadherin in Figure 23, as the 
transcription factor has been shown  to repress E-cadherin expression and re-
model the actin cytoskeleton in a number of EMT’s in cancer (Zhang et al., 
2011; Yilmaz and Christofori, 2009) .  These changes, as previously mentioned, 
allow a change in cellular architecture and an increase in cellular motility 
(Figure 23). 
 
As the signaling basis behind the contribution of Lamin A to Slug up-regulation 
is un-known, future experiments should also look to elucidate these. Lamin A 
has a significant number of signaling partners (Andrés and Gonzàlez, 2009). In 
prostate cancer Lamin A-induced an increase in prostate cancer cell motility 
which was identified as a result of signaling through the PI3K/PTEN pathway 
(Kong et al., 2012). This pathway would therefore make an interesting target of 
study in SW480 colorectal cancer cells. As TGFβ is an established signaling 
partner to the Lamin A protein (Van Berlo et al., 2005) and has shown evidence 
of increased activity in SW480/Lamin A cells (Foster, 2011 PhD Thesis), it has 
been indicated as the initial effector on the expression of Lamin A and of Slug in 
the proposed EMT signaling pathway (Figure 23).  Future work may look to also 
determine the levels of TGFβ in SW480/Lamin A cells at low cell density to 
observe whether signaling is induced in SW480/Lamin A cells and whether it 
contributes to Slug expression. TGFβ is a well-known tumour promoter and 
inducer of EMT, and induction of TGFβ signalling induces downstream PI3K and 
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MAPK signalling (Zavadil and Bӧttinger,  2005). These pathways are implicated 
in tumour cell motility and migration. TGFβ signalling is also able to induce 
expression of Slug in a number of different tissues (De Craene et al., 2005) and 
therefore forms the primary candidate for future signaling studies (Figure 23). 
 
Together these results confirm speculations made by Foster (2011- PhD thesis) 
that the presence of Lamin A expression in SW480 colorectal cancer cells 
induces mesenchymal characteristics in SW480 cells. As Lamin A modulates the 
expression of a number of signaling pathways, expression of Lamin A is SW480 
cells permits a signaling environment that allows EMT to occur. This effect was 
particularly marked in cells cultured at low cell density and also at the edges of 
scratch wounds, which are both environments that are permissible of increased 
cellular motility and migration. As a link is thus established between Lamin A 
expression and cancer cell metastasis in SW480 colorectal cancer cells,  future 
work should look to further elucidate the molecular signaling mechanisms 
behind this phenomenon and to explore whether Lamin A contributes to a 
mesenchymal cell phenotype in other cancer cell lines, such as breast, ovarian 
and lung.  This would allow us to determine the extent to which Lamin A 
contributes to a more agressive cancer cell phenotype in other kinds of cancer 
and to further elucidate the role of Lamin A in a variety of cancers. 
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Figure 23: Proposed EMT signalling pathway in SW480 cells that is mediated by 
Lamin A expression.  
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